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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation Hypothesis 
This dissertation research evaluates the effect that 
dietary ethanol has on the health of the circulatory system. 
The effect of dietary ethanol on previously established 
atherosclerotic disease has never been addressed by either 
human or animal studies. Given that ethanol consumption 
promotes anti-atherogenic changes in cholesterol metabolism, 
enzyme activities and atherogenic stimuli, it is the proposal 
of this dissertation that the consumption of ethanol will 
promote the regression of previously established 
atherosclerotic lesions. Furthermore, because the 
atherosclerotic process is similar in the man and rabbit, 
this dissertation proposes to use atherosclerotic rabbits as 
a model for the effects of ethanol on atherosclerotic people. 
Dissertation Organization 
The chapters are organized after Chapter 1 in the 
following manner. Chapter 2 consists of a review of the 
literature which examines the development and regression of 
the atherosclerotic process, how ethanol has been shown to 
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affect atherosclerosis and concludes with the hypothesis for 
the dissertation. Chapter 3 evaluates the affects that a 
cholesterol-free diet, with or without ethanol, has on plasma 
lipoprotein-cholesterol and atherosclerotic severity. 
Chapter 4 evaluates the affects that a cholesterol-free diet, 
with or without ethanol, has on arterial contractile 
properties. Chapter 5 concludes the dissertation and 
discusses the general conclusions resulting from this 
dissertation. Appendix 1 presents a statistical analysis of 
the time-dependant changes observed in the plasma lipid 
concentrations described in Chapter 3. Appendix 2 evaluates 
how ethanol affects vasoconstriction in sheep umbilical 
arteries and how this may be a useful model for studying the 
causes of fetal alcohol syndrome in humans. The materials 
contained in Chapter 3 and 4 represents two papers that will 
be submitted to the Journal of Comparative Biochemistry and 
Physiology for publication; these two chapters are written 
according to the requirements for publication in this 
journal. The remaining materials are written according to 
the rules outlined in the Fifth Edition of the Council of 
Biology Editors Writers Guide. 
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CHAPTER 2. REVIEW OF THE LITERATURE 
The Atherogenic Process and Development of Heart Disease 
Atherosclerosis and its effect on the population 
In 1990 some 486,000 Americans died of coronary heart 
disease. One of the most important and frequent post-mortem 
findings in these people were atherosclerotic deposits in the 
coronary arteries. These cholesterol-rich deposits cause a 
narrowing of arterial lumens and are frequently associated 
with sites of thrombosis or vasospasm, leading to occlusions 
and reduced blood flow to an effected portion of the 
myocardium. Due to the extremely high oxidative metabolic 
rate of the heart, a reduction in blood flow quickly results 
in hypoxia causing myocardial injury or necrosis. Thus, 
atherosclerosis is an essential part of what is termed heart 
disease and can result in myocardial infarction. 
Atherosclerosis is unique when compared to other diseases 
because of the chronic course of its development, taking up 
to decades for clinical manifestation. The first signs of 
atherosclerosis are fatty streaks lining the arterial lumen. 
Fatty streaks are clinically benign lesions consisting of 
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cholesterol and fat deposits in the arterial wall. They 
become detectable in 65% of children by the age of 12 to 14 
years of age (Stary 1989). Fatty streaks do not cause overt 
symptoms of disease, such as loss of cardiovascular function, 
but they do represent sites with the potential to progress 
into a more pathological atherosclerotic lesion, a process 
called atherogenesis. Atheromas represent areas where the 
fatty streaks have grown larger, with smooth muscle 
hypertrophy or proliferation, and a necrotic core resulting 
in lesion encroachment into the arterial lumen (Stary 1989). 
In the final stages of atherogenesis, the atheroma leads to 
the development of fibrous plaques, characterized by deposits 
of calcium and collagen in the arterial wall. 
What is the etiology of factors promoting the development 
of the fatty streaks initiating the process of 
atherosclerosis and cardiovascular damage? Once 
atherosclerosis is present, how can progression be checked? 
If progression can be checked, are treatments available to 
reverse the process and return the vascular system to a more 
healthy status? Understanding the etiology of events which 
lead to atherosclerosis is the first step to addressing these 
issues. 
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Evolution of arterial tissue from a healthy to an 
atherosclerotic status 
Fatty streaks form as focal sites underneath the 
endothelium where monocytes from the blood have infiltrated 
into the area in between the endothelium and the basement 
membrane. They then fill with lipid and cholesterol esters 
becoming swollen macrophages, loosely termed 'foam cells' 
(Stary 1989). The exact stimulus for the initial migration 
is not clear. Some suggested possibilities have included 
intimal infection by viruses (Span et al. 1991), local 
endothelial damage (Ross 1973) and circulatory turbulence 
(Zarins et al. 1983). 
The heart tends to be one of the first organs affected by 
atherosclerosis, as well as one of the organs most severely 
affected because it has a large number of arterial 
bifurcations and a tremendous number of sites of circulatory 
turbulence (Zarins et al. 1983). Hence, the myocardium has a 
tremendous number of sites favoring fatty streak and 
atherosclerotic establishment. In contrast, the venous 
system is almost never affected by atherosclerosis because of 
the small amount of turbulence found there. 
Monocytes and the macrophages derived from monocytes, 
directly mediate a series of events resulting in the 
promotion of fatty streaks. Beneath the endothelium. 
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macrophages release mediators including free radicals like O2" 
, chemoattractants, cytokines and growth factors (Ross 93). 
At the lesion site, these chemicals promote increased 
capillary permeability, additional monocyte and leukocyte 
recruitment and smooth muscle proliferation, resulting in a 
classic positive feedback loop promoting continued lesion 
growth. 
Because macrophages mediate increased endothelial 
permeability, they also increase the permeability of the 
endothelium to low density lipoprotein (LDL) particles and 
increase the amount of LDL at the lesion site (Ross 1993) 
These micelle-like particles are rich in cholesterol, carry a 
single molecule of a protein called apolipoprotein B-lOO (apo 
B-lOO) and are primarily responsible for cholesterol 
deposition in peripheral cells (Ross 1993). 
Normally, LDL-particles are only slowly taken up by 
sources outside the liver after binding to apo B-lOO 
receptors on cell membranes (Kreiger 1992). To promote high 
LDL uptake rates, LDL must first be chemically modified. LDL 
lipid and/or protein modifications may include attachment of 
acetyl or aldehyde groups, malondialdehyde or proteoglycans 
as well as direct lipid oxidation. Because oxidative 
modification has been proven to occur in vivo, oxidized-low 
density lipoproteins (ox-LDL) appear to represent the most 
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important modified LDL particles (Sparrow 1989; Palinska et 
al. 1989). 
LDL may be oxidized by a variety of mechanisms. Oxidation 
can be facilitated by endothelially derived free radicals 
(Steinbrecher et al. 1984). Activated platelets may also 
oxidize LDL lipids through the action of a protein 
originating from the alpha granules during platelet 
aggregation (Fuhrman et al. 1991). However, the primary LDL 
oxidizer appears to be macrophages. The mechanism apparently 
utilizes free radicals released in association with the 
respiratory burst and/or released lipoxygenase (Carpenter et 
al. 1991). 
In contrast to normal LDL particles, the ox-LDL particle 
binds with high affinity to scavenger receptors on cell 
membranes, is rapidly internalized (Kreiger et al. 1992) and 
preferentially accumulates at sites of atherosclerosis (Chang 
et al. 1993). Furthermore, ox-LDL particles serve as 
chemoattractants to monocytes in the circulation. 
(Parthasarathy et al. 1986). Thus, macrophages promote an 
increased rate of cellular cholesterol uptake by increasing 
LDL permeability, LDL oxidation and macrophage infiltration, 
thereby promoting increased cholesterol uptake by cells 
localized to the lesion site. 
Cells, including macrophages, take up LDL and ox-LDL 
particles by endocytosis, leading to LDL degradation in a 
8 
lysosome. In macrophages the cholesterol esters are 
sequestered to a lipid pool in the cells center. As the 
content of cholesterol esters sequestered to the center of 
cells increase, the macrophages become swollen, growing 
larger and more spherical and ultimately lose their ability 
to leave the lesion area (Fielding 1992; Inoue et al. 1991; 
Brown et al. 1980). These macrophages become trapped between 
the endothelium and the basement membrane. Because they 
continue to signal inflammation and promote LDL oxidation, 
they continue to promote infiltration of macrophages and LDL 
at the lesion site (Badimon et al. 1993). As macrophages 
continue to enter and swell, the affected region begins to 
encroach upon the arterial lumen, creating circulatory 
turbulence within the lumen. This turbulence creates 
conditions that further promote the inflammatory response of 
the macrophages within the fatty streak. The factors 
involved in the establishment and development of the 
atherosclerotic process are reviewed in Figure 1. 
Cholesterol transport to and from the periphery 
The primary facilitators of cholesterol transport to 
peripheral targets are LDLs. Tissue like the ovaries, 
adrenal cortex and testis all have high metabolic demands for 
Figure 1. Review of factors leading to the promotion of fatty 
streaks and atherosclerosis in the arterial wall. 
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sterols and hence express large numbers of apo B-lOO 
receptors for LDL particles and an increased ability to take 
up LDL particles (Brown and Goldstein 1983). Although apo B-
100 receptors are present in most tissues, the amount of LDL-
cholesterol taken up by apo B-lOO mediated uptake appears to 
be small, with prior LDL oxidation being required for high 
affinity uptake by a second LDL receptor class, the scavenger 
receptors. Scavenger receptors work in a very non-specific 
fashion to rapidly take up chemically modified LDL, like ox-
LDL, at a rate much greater than that of unmodified LDL 
particles (Sparrow et al. 1989). 
LDL particles represent the degradation product of a 
lipoprotein called the very low density lipoprotein (VLDL). 
Clinically, VLDL particles have a density range of 0.95 to 
1.006 g/cm' (Havel, Eder and Bragdon 1955). VLDLs are 
primarily secreted from the liver, are rich in triglycerides 
and contain only a small amount of cholesterol. While the 
entire VLDL particle can be endocytosed, typically only the 
triglycerides are removed by the action of lipoprotein lipase 
upon association of the VLDL particle with the endothelium. 
When endocytosis does occur, it is mediated by a 550 kd 
protein called apo B-lOO that serves as the receptor ligand 
of the lipoprotein, signalling endocytosis at the target 
cell. VLDL may be directly endocytosed when an additional 
apolipoprotein called apolipoprotein E (apo E) finds its 
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receptor. (Basu et al. 1983; Yamada et al. 1992; Nordesgaard 
et al. 1992) 
VLDLs also carry a series of apolipoprotein C proteins 
termed apo CI, apo CII and apo CIII. Apo CII is the most 
important because it serves as a coenzyme for extrahepatic 
LPL activation (Gomez-Coronado et al. 1993). Lipoprotien 
lipase activation catalyzes the hydrolysis of triglycerides 
from the triglyceride rich VLDL particle, forming free fatty 
acids and facilitating fatty acid efflux into peripheral 
target cells. 
After removal of the triglycerides from the VLDL core, apo 
E, apo CI, apo CII and apo CIII dissociate, leaving only apo 
B-100. The remnant is called the LDL lipoprotein and is 
composed of approximately 50% cholesterol esters, 30% 
phospholipids and a small amount of triglycerides and free 
fatty acids. Clinically, LDLs are identified as lipoproteins 
with a density of 1.019 to 1.063 g/cm' (Havel et al. 1955). 
The Report of the National Cholesterol Education Program 
(NCEP; 1988) suggests that people with plasma LDL-cholesterol 
levels in excess of 160 mg/dl are at high risk for 
development of coronary artery disease and should receive 
follow up dietary or drug intervention. A variety of 
treatments are available and clinically used, some of which 
will be discussed later. 
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Endocytosis of LDL or ox-LDL particles in the periphery or 
the liver results in complete degradation of the lipoprotein 
contents within the lysosome where cholesterol esters are 
hydrolyzed to free cholesterol. After leaving the lysosome, 
free-cholesterol if re-esterified by cellular acyl-
CoA:cholesterol acyltransferase (ACAT), which adds a fatty 
acid at the C-3 position of cholesterol. These neutrally 
charged cholesterol esters are then sequestered to the center 
cholesterol ester lipid pool of the cell (Fielding 1992). 
Hence, apoproteins on the VLDL particle may be reused, but 
the LDL particle and its contents are degraded within the 
target cell. 
High density lipoprotein particles oppose the cholesterol 
depositing functions of LDL particles. Peripheral 
cholesterol is taken up and removed by HDL particles for 
redistribution in the body. HDL particles are the smallest 
and most dense lipoprotein particles with a density of 
between 1.063 and 1.21 g/cm' (Havel et al. 1955). The NCEP 
(1988) has determined that plasma HDL cholesterol levels 
below 35 mg/dL are associated with an increased risk of 
coronary artery disease and that plasma levels above this 
result in reduced risk of coronary artery disease. 
HDL particles are secreted by hepatocytes as discoidal 
particles that are rich in phospholipids and generally free 
of cholesterol (Tall 1990). Free cholesterol in the outer 
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membrane of peripheral cells is able to diffuse into the HDL 
particle along its concentration gradient and is rapidly 
esterified at C-3 with a fatty acid removed from a 
phospholipid like phosphatidylcholine by lecithin;cholesterol 
acyltransferase (LCAT). Because cholesterol esters are 
electrically neutral, the esters remain in the neutrally 
charged HDL core. Furthermore, once esterified, cholesterol 
is unable to leave the HDL particle without facilitated 
diffusion. As the discoidal particle continues to take up 
and esterify cholesterol, the particle becomes swollen and 
takes on its mature, cholesterol ester rich, spherical 
appearance (Tall 1990). 
Several enzymes are associated with HDL function. LCAT 
and its co-factor apo AI function to esterify free 
cholesterol (Tall 1990; Rubanyi et al. 1990). Apo All has 
been proposed to inhibit HDL uptake of free cholesterol from 
cells and promote atherogenesis (Fruchart et al. 1993; Warden 
et al. 1993). Cholesteryl ester transfer protein (CETP) 
facilitates the exchange of cholesterol esters from the HDL 
core, for triglycerides of apo B~100 containing lipoproteins 
like LDL and VLDL. In contrast to VLDL and LDL particles, HDL 
particles do not carry the apo B-lOO protein. The apo C 
series become associated with HDL particles after their 
dissociation from VLDL particles, but appear to have little 
function while associated with HDL particles (Tall 1990). 
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Finally, apo E becomes associated with HDL and serves as a 
receptor for HDL uptake and endocytosis (Basu et al. 1983; 
Yamashita et al. 1990). 
The cholesterol esters within HDL particles have a variety 
of potential destinations, with one being the peripheral 
tissues from which the cholesterol originated via apo E 
mediated uptake. However, the primary destination of HDL and 
its associated cholesterol is deposition in the liver. HDL 
associated apo E signals endocytosis via apo E receptors 
(Goldberg et al. 1991). Because macrophages within the 
atheroma may also secrete apo E and express apo E receptors, 
they can directly modify the removal of cholesterol laden 
cells of the atheroma. 
The cholesterol esters in an HDL particle can also be 
transported to VLDL and LDL particles without HDL degradation 
(Brown et al. 1980). CETP catalyzes the exchange of 
cholesterol esters from the core of HDL particles for 
triglycerides of apo B-lOO containing particles (Tall 90). 
Increased CETP activity is associated with increased 
sensitivity to dietary cholesterol. In terms of phylogenetic 
relationships, both rabbits and man have relatively high 
plasma CETP activities as well as a tendency to develop 
atherosclerosis when exposed to diets rich in cholesterol for 
prolonged periods. In contrast, animals like the mouse have 
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relatively low CETP activity and tend not to readily form 
atheromas when fed high cholesterol diets (Ha and Barter 
1982) . 
In transclonal rodent experiments using mice expressing 
the human CETP gene, when CETP activity is increased the mice 
become sensitive to dietary cholesterol (Marotti et al. 
1993). In contrast, transgenic mice expressing increased 
levels of the apo AI are less sensitive to dietary 
cholesterol and fatty streak development (Rubin et al. 1991). 
In contrast, mice become atherogenic when apo All, which 
inhibits the action of apo AI, is over expressed (Warden et 
al. 1993). Finally, human studies of enhanced CETP activity 
associated with some familial hypercholesterolemics and 
persons without CETP activity due to a lack in the CETP gene, 
support the idea that CETP is important in diverting HDL 
cholesterol back into atheroma formation in the periphery 
(Inazu et al. 1992; Yamashita et al. 1990). 
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Atherosclerosis Results in Modified Vascular 
Vasoconstriction and Vasodilation 
The endothelium separates plasma constituents from the 
tissues of the arterial wall 
Before humoral materials can pass from the arterial lumen 
into foam cells or smooth muscle cells of the atherosclerotic 
arterial wall, the materials must first pass across a 0.3 to 
0.4 jum thick layer of endothelial cells that line the inner 
surface of all healthy arteries (Crapo et al. 1983). These 
cells are central to determining the effect that plasma 
constituents will have on the physiology of the arterial 
wall. The primary purposes of endothelial cells are as 
follows; 1) To provide the vascular system with a endothelial 
surface facilitating laminar blood flow, 2) To prevent 
platelet aggregation, 3) To serve as a selectively permeable 
barrier regulating passage of plasma constituents to the 
underlying vascular smooth muscle, and 4) To directly 
regulate the contractile status of the vascular smooth muscle 
lying underneath the endothelium. All of these functions 
become suppressed during the progression of atherosclerosis. 
The caliber of a vessel lumen is determined by the degree 
of constriction maintained by vascular smooth muscle and the 
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interplay of cellular and humoral factors on the vascular 
smooth muscle cells. At a focal site these factors, to be 
detailed later, may facilitate vasodilation or an increase in 
the arterial lumen diameter associated with increased blood 
flow to dependent sites and decreased vascular resistance. 
These factors can also promote vasoconstriction, or a 
decrease in the lumen diameter leading to decreased blood 
flow and increased resistance. As explained earlier, a 
vasospasm in the coronary arterial system represents a focal 
site of severe vasoconstriction that can cause reduced 
coronary blood flow leading to a myocardial infarction. The 
development of the atherosclerotic process alters endothelial 
function leading to conditions promoting vasospasm (Meredith 
et al. 1993) . 
The endothelium promotes vasodilation by releasing a compound 
called endothelium-derived relaxing factor 
A healthy endothelium is critical for maintaining vascular 
smooth muscle in a relatively relaxed state of contraction. 
The endothelium does this by releasing endothelium-derived 
relaxing factor (EDRF), a chemical believed to be nitric 
oxide (NO) (Palmer et al. 1987). While basal EDRF production 
exists (Chester et al. 1990), EDRF production from 
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endothelial cells is stimulated by many factors including 
acetylcholine (Furchgott and Zawadski 1980), catecholamines, 
serotonin, thrombin and increased blood flow along the 
endothelium (Meredith et al. 1993). 
EDRF is primarily generated by endothelial cells through 
the action of calmodulin-calcium dependent NO synthase (Bredt 
and Snyder 1990), which generates NO by removing the terminal 
guanidino-group of L-arginine (Palmer et al. 1988). 
Secondary sources of EDRF have been found to include 
platelets (Radomski et al. 1990), macrophages (Yates et al. 
1992) and smooth muscle cells themselves (Schini et al. 
1991). Because EDRF is readily diffusible, it rapidly 
diffuses into both the arterial lumen and across the basement 
membrane to EDRF receptors on vascular smooth muscle cells. 
At its target, the EDRF-receptor interaction results in 
activation of guanylcyclase, increasing the intracellular 
cyclic guanylnucleotide monophosphate concentration [cGMP]; 
(Bossaller et al. 1987). The increase in the [cGMP]; 
activates cGMP-dependent protein kinase and inhibits calcium 
entry into the target cell (Waldman and Murad 1987). 
Physiologically the elevated [cGMPj] decreases the 
intracellular calcium concentration and promotes relaxation 
(vasodilation) of vascular smooth muscle as well as 
inhibiting calcium dependent platelet aggregation (Scott-
Burden and Vanhoutte 1993). 
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The bioactivity of factors like epinephrine, 
norepinephrine, acetylcholine and serotonin is dependent upon 
whether a functional or dysfunctional endothelium overlays 
the smooth muscle. When these factors bind to their 
receptors on smooth muscle cells they cause smooth muscle 
cell contraction. However, when these factors bind to 
receptors on healthy endothelial cells, they cause the 
endothelium to release EDRF. Endothelium-derived relaxing 
factor serves as a potent physiological antagonist of the 
vasoconstrictor properties of the above factors that 
stimulated their release, such that vessels lined with a 
functional endothelium dilate in spite of the presence of 
constrictors. In contrast, vessels lacking a functional 
endothelium lack physiological antagonists to the 
vasoconstrictor properties of these compounds, predisposing a 
vessel to vasospasm (Meredith et al. 1993) . 
Hypercholesterolemia and atherosclerosis attenuate 
endothelially mediated vasodilation 
The progression of the atherosclerotic process is linked 
to a loss in EDRF mediated vasodilation. In Watanabe 
heritable hyperlipidemic rabbits, changes in vascular 
reactivity during the atherogenic process appear to be 
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associated with a progressive loss of functional endothelial 
cells (Kolodigie et al. 1990). In an in vivo study of 
monkeys Macaca fascicularis. McLenachan et al. (1991) proved 
that EDRF mediated vasodilation and increased blood flow into 
femoral artery caused by intravenously administered 
acetylcholine is attenuated early in the development of 
atherosclerosis. 
Similar effects have been observed for human 
atherosclerotic vessels. The atherogenic process leads to a 
loss of EDRF mediated vasorelaxation in human epicardial 
arteries when examined in vitro (Forstermann et al. 1988). 
Substance P and the thromboxane analog U46619 normally 
stimulate endothelial release of EDRF, but the release is 
attenuated when atherosclerotic human coronary arterial rings 
are used (Chester et al. 1990). Furthermore, the inhibitor 
of NO synthase N°-monomethylarginine (NMMA) can also be used 
to show that human atherosclerotic vessels have reduced EDRF-
mediated relaxation in the basal (non-stimulated) state 
(Chester et al. 1990). 
Endothelium-mediated vasodilation has been shown, by using 
a bioassay, to be inhibited by atherosclerosis in rabbit 
aortas. Verbeuren et al. (1990) showed that exogenously 
administered NO produces less vasodilation in atherosclerotic 
abdominal and thoracic vessels segments than in non-
atherosclerotic control rabbits. The abdominal and thoracic 
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aortas were also treated with acetylcholine to stimulate the 
release of EDRF. By collecting the tissue-bathing fluid and 
transferring the fluid to a detector tissue ring, it was 
shown that EDRF derived from atherosclerotic vessels were 
less able to promote endothelium-mediated vasodilation of 
paired EDRF detector vessels. 
The observations of Verbeuren et al. (1990) were partially 
confirmed by Minor et al. (1990) who used a bioassay protocol 
coupled to a chemiluminescence detector set to determine the 
production of the primary NO metabolite NO3". Minor et al 
(1990) studied rabbit aortas from control and atherosclerotic 
individuals, in addition to aortas removed from rabbits 
maintained on a short-term cholesterol-enriched diet such 
that hypercholesterolemia was developed (1448 ± 68 mg 
cholesterol/dl) and intimal lesions had not yet developed. 
To determine EDRF production, they used detector vessels, 
porcine arterial rings removed from the proximal left 
circumflex coronary arteries. They also observed that 
atherosclerotic vessels and vessels from hypercholesterolemic 
rabbits in which fatty streaks had not been established 
dilated less at the basal level and when stimulated to dilate 
with acetylcholine. In addition, they observed that 
vasodilation of the detector vessels was also decreased. 
In the circulation, NO is oxidized to NO3" (Stamler et al. 
1992). Minor et al. (1990) used chemiluminescence to 
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directly measure NOs", as a measure of NO production by 
control, atherosclerotic and hypercholesterolemic vessels 
under basal and acetylcholine-stimulated conditions. 
Paradoxically, they observed that the hypercholesterolemic 
and atherosclerotic vessels actually generate more NO than 
did control arterial segments. This observation is supported 
by evidence for increased nitric oxide synthase induction in 
the aortas of cholesterol-fed rabbits (Verbeuren et al. 
1993). Thus, in some poorly understood manner, diseased 
vessels are producing more EDRF, but are less able to dilate, 
possibly because NO is more rapidly converted into the 
inactive metabolite NO3". 
Hypercholesterolemia and increased levels of LDL-
cholesterol are associated with increased amounts of LDL 
oxidation. In an experiment using coronary arterial rings 
removed from pigs, LDL particles were oxidized by reacting 
them with copper. These ox-LDL particles were found to 
prevent endothelium dependent vascular dilation in response 
to serotonin. In contrast, unoxidized or native LDL 
particles were not found to affect endothelially dependent 
relaxation of vessels by serotonin (Simon et al. 1990). 
Degradation of EDRF by ox-LDL has been implicated from 
studies of fetal lung cultured fibroblasts (Chin et al. 
1992). A scavenger of Oj" radicals, Oj" dismutase, was shown 
to promote vasodilation in aortic rings from cholesterol-fed 
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rabbits (Mugge et al. 1991). Their observations suggest that 
hypercholesterolemia results in excess production of O^ ' 
radicals and that EDRF degradation caused by O2. results in 
the attenuated endothelium-dependent vasodilation associated 
with hypercholesterolemia and atherosclerosis (Mugge et al. 
1991). 
Oxidized-LDL particles are produced by the reaction of Oj. 
with LDL particles and have been found to be very important 
in determining why vessels from hypercholesterolemia and 
atherosclerotic individuals are less able to maintain their 
vasodilated state. In rabbit and human arteries, ox-LDL 
particles and the attenuation of arterial dilation are 
associated with a decrease in the tissue cGMP content (Galle 
et al. 1992). A more recent study of cholesterol-fed rabbits 
reported that, in addition to a reduction in tissue cGMP, ox-
LDL reduces the activity of tissue guanlycyclase in vessels 
from hypercholesterolemic rabbits (Schmidt et al. 1993). The 
reduced guanlycyclase activity could result in reduced 
amounts of intracellular cGMP and reduced inhibition of 
intracellular calcium entry as well as reduced cGMP dependent 
protein kinase activation. As a result, smooth muscle cells 
should theoretically tend toward vasoconstriction promoted by 
the binding of vasoconstrictors to receptors on the smooth 
muscle cell membrane. 
Furthermore, EDRF has been shown to prevent the oxidative 
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modification of LDL particles by Oj" from macrophages and 
leukocytes in vitro (Yates et al. 1992; Rubanyi et al. 1991). 
By sharing its unpaired electron, NO is able to neutralize O2' 
and prevent Oj'-dependent modification of LDL particles (Yates 
et al. 1992) , but by doing so EDRF becomes converted to NO3" 
and loses its dilating properties. Because macrophage-
derived Oj" represents a site of EDRF loss, a potential 
deficit of EDRF could be promoted in arterial regions 
affected by macrophage-rich fatty streaks or atherosclerosis. 
Exogenously administered L-arginine has been shown to 
partially reverse the loss in endothelium-dependent 
vasodilation in rabbits fed cholesterol, presumably by 
increasing the substrate for EDRF formation and compensating 
for the increased EDRF degradation by ox-LDL when the 
endothelium was stimulated with acetylcholine, though the 
effect of L-arginine administration in vivo is controversial 
(Girerd et al. 1990). 
The preceding discussion has made it clear that the 
atherogenic process is linked to changes in vascular 
responsiveness. Because the vasodilatory message of 
compounds like catecholamines, acetylcholine and EDRF is lost 
during atherosclerosis, evaluation of the bioactivity of 
these compounds on arterial tissue will provide information 
as to the extent or severity of the disease present in an 
artery of interest. 
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Endotbelin is a recently discovered protein whose functions 
in regards to atherosclerosis are rapidly being discovered 
In contrast to the vasodilatory properties of EDRF, the 
endothelium has also been found to secrete a very potent 
vasoconstrictor. The existence of an endothelially 
originating vasoconstrictor was first suggested by Hickey et 
al. (1985) and later characterized as a small sized, short 
lived peptide by Yanagisawa et al. (1988) who called it 
endothelin. It was rapidly recognized that tissue and 
circulating levels of the peptide were positively correlated 
with the degree of atherosclerotic involvement (Lerman et al. 
1991). Because endothelin potentiates coronary arterial 
contractile responsiveness to threshold levels of 
norepinephrine and serotonin, in addition to amplifying the 
force of contraction, endothelin may be important in 
promoting coronary arterial vasospasm (Yang et al. 1990). 
Like EDRF, endothelin is secreted at both basal and 
stimulated levels (Boulanger and Luscher 1990). Stimulants 
of endothelin secretion have been proven to include thrombin, 
epinephrine, calcium ionophores and low shear stress (Luscher 
et al. 1992). EDRF has been shown to inhibit thrombin 
stimulated endothelin release from the endothelium (Boulanger 
and Luscher 1989). Because increased endothelin secretion is 
associated with sites of low shear stress and atherosclerosis 
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(Lerman et al. 1991), endothelin secretion may represent a 
signal of endothelial disfunction to the underlying tissues. 
The secretion of endothelin appears to promote the 
progression of the atherogenic process though a number of 
mechanisms. Endothelin promotes the atherogenic process by 
acting on smooth muscle cells. Endothelin serves as a co-
mitogen to stimulate smooth muscle cell proliferation, a 
process believed to be especially important in the re-
occlusion of arteries following angioplasty (Weissberg et al. 
1990). Endothelin has also been found to have strong 
chemoattractant properties for promoting the migration of 
circulating monocytes into the arterial wall (Achmad and Rao 
1992), thus increasing the potential for foam cell generation 
and macrophage mediated LDL oxidation. 
The effects of ox-LDL on endothelin production are not 
well understood. Boulanger et al. (1992) have suggested that 
ox-LDL increases endothelial production of endothelin peptide 
and mRNA, and by this mechanism could provide a positive 
feedback loop, promoting local increases in endothelin at 
sites of atherosclerosis. However, negative controls may 
exist, Jougasaki et al. (1992) have suggested that 
lysophosphatidylcholine carried by ox-LDL can reduce the 
secretion of endothelin from endothelial cells. The 
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observations of these investigators appear contradictory and 
represent part of the immaturity of this rapidly changing 
field. 
A link between atherosclerosis and endothelin clearly 
exists. Given that endothelin has only recently been 
discovered, a more complete understanding of how endothelin 
interacts with atherosclerosis and the complications of 
atherosclerosis will hopefully be forthcoming in the near 
future. 
Evaluation of Atherosclerotic Regression in 
the Human and Rabbit 
Evidence for regression of atherosclerotic lesions from 
clinical studies 
Regression of atherosclerotic lesions is a goal in the 
treatment of established coronary heart disease. Clinical 
treatment of coronary heart disease typically involve some or 
all of the following: adherence to the American Heart 
Association Step 1 or Step 2 diets, therapy with lipid 
lowering drugs to decrease LDL-cholesterol and increase HDL-
cholesterol, as well as moderate exercise (NCEP 1988). These 
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measures have variable levels of success. At a minimum, 
these measures typically slow down atherosclerotic 
progression and occasionally promote regression of 
established atherosclerotic lesions. Atherosclerotic 
regression in a diseased artery is indicated by any or all of 
the following changes: increased arterial lumen diameter, 
decreased atherosclerotic plaque thickness or decreased total 
arterial wall thickness. 
Aggressive lipid lowering therapy has been found to 
promote atherosclerotic regression in humans. The 
Cholesterol Lowering Atherosclerosis Study (CLAS; Blankenhorn 
et al. 1987) administered a combination of the lipid lowering 
drugs colestipol and niacin. Two years later LDL- and HDL-
cholesterol were modified by -43% and +37%, respectively, 
whereas the control group had changes of -5% and +2% for LDL-
and HDL-cholesterol, respectively. Atherosclerotic 
regression was more likely to occur in the drug treated 
individuals (16.2% of individuals) than in the placebo 
treated individuals (2.4%), significance was P=0.002. 
Following the patients from their previous study, Blankenhorn 
et al. (1993) found that subjects receiving drug therapy had 
significant reductions in carotid arterial thickness after 
both 2 years (P=0.0001) and 4 years (P=0.0001) of drug 
therapy, in contrast placebo treated patients tended to show 
continued arterial wall thickening. 
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Atherosclerotic regression has also been validated in a 
two and one half year long study of coronary artery disease 
and lipid-lowering drug therapy with a combination of either 
lovastatin and colestipol or niacin and colestipol (Brown et 
al. 1990). Atherosclerotic regression was promoted in both 
drug treatment groups when compare to a placebo group 
receiving a cholesterol-lowering diet alone. While the 
lipid-lowering therapy promoted beneficial changes in the two 
drug treated groups, the plasma LDL- and HDL-cholesterol 
concentrations of the placebo treated participants were 
unchanged and little atherosclerotic regression was observed; 
ominously, mortality was also greatest within the placebo 
treated group. 
Atherosclerotic regression can also be promoted by 
exercise and dietary modification (Schuler et al. 1992) and 
what are broadly termed ^Comprehensive Lifestyle Changes' 
(CLC) (Ornish et al. 1990). CLC consists of stress 
management training, moderate exercise and a strictly 
observed vegetarian diet that is very low in cholesterol and 
saturated fat (Ornish et al. 1990). After 12 months, LDL-
cholesterol was significantly lower in the CLC group than in 
the control group, 2.46±1.55 verses 4.07±1.17 mmol/L, 
respectively (P<0.007), furthermore, chest pain was least in 
the CLC group (P<0.0006). Average lesion scores (12 month % 
lesion stenosis - initial % lesion stenosis) in the CLC group 
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changed in the direction of regression in 18 of 22 patients, 
with increased adherence to CLC being positively associated 
with increased atherosclerotic regression. In the control 
group atherosclerotic progression was observed in 10 of 19 
participants and in only 8 of 19 was any regression observed. 
The study suggests that conventional recoinmendations for 
patients with coronary heart disease, such as adherence to a 
diet with 30% of calories as fat may not be sufficient to 
bring about regression in most patients and that aggressive 
CLC can promote atherosclerotic regression in most patients. 
Schuler et al. (1992) evaluated atherosclerotic regression 
in patients with coronary heart disease induced stable angina 
patients assigned to a low-fat diet containing less than 20 
percent of total calories with a polyunsaturated-to-saturated 
fatty acid ratio of less than one to one, and less than 200 
milligrams of cholesterol per day, either by itself or with 
exercise. Assessment of coronary arterial morphology 12 
months latter revealed that progression had occurred in 42% 
and 20% of individuals in the control and exercise group 
members respectively. Regression was observed in 4% and 30% 
of the control and intervention individuals, respectively. 
Furthermore, physical work capacity, myocardial oxygen 
consumption and stress-induced myocardial ischemia were all 
significantly improved in the exercise group. In conclusion, 
although exercise did not promote regression in all 
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participants, cardiovascular improvements were most likely to 
be occur in exercising individuals. 
These studies of human atherosclerotic regression suggest 
four things: 1) That dramatic reductions in plasma LDL-
cholesterol and dramatic increases in HDL-cholesterol are 
associated with the promotion of atherosclerotic regression, 
2) Adherence to the American Heart Association Step 1 or Step 
2 lipid lowering diets alone may not facilitate changes in 
plasma lipids conducive of atherosclerotic regression, 3) 
Although healthy changes in plasma lipids may occur, 
atherosclerosis in an individual may be resistant to 
regression and 4) These studies also show the complicated 
nature of human studies and how treatment compliance makes 
the human model of atherosclerotic regression particularly 
difficult to control and evaluate. 
The rabbit as a non-hiunan model for the evaluation of 
atherosclerotic regression 
Atherosclerotic regression has been documented in a 
variety of non-human species including chickens, rats, dogs, 
pigeons, pigs, non-human primates and rabbits for a complete 
list see Manilow 1983. Of the non-primate models for human 
disease, the rabbit model is one of the most popular. The 
33 
popularity of rabbits stem from the relative ease by which 
the atherosclerotic process can be stimulated by dietary 
cholesterol, their relative low cost and because the lesions 
in the arterial lesions are similar to those developed in man 
(Duff 1936; Guyton and Klemp 1992). 
It has long been recognized that rabbits develop 
atherosclerosis rapidly when cholesterol is included as a 
dietary supplement (Duff 1936). When hypercholesterolemia is 
induced by supplementing the diet with cholesterol, 
cholesterol esters accumulate in apo B-lOO lipoproteins. In 
humans these cholesterol esters accumulate predominantly in 
the LDL fraction, but in rabbits dietary cholesterol tends to 
accumulate as cholesterol esters in both the VLDL and LDL 
fractions (Daugherty et al. 1986) . Because both humans and 
rabbits tend to develop atherosclerotic lesions after 
inducement of hypercholesterolemia, the fact that different 
lipoproteins serve as the primary reservoir for circulating 
cholesterol appears to make little difference on the 
atherosclerotic lesions that develop. 
The process of atherosclerotic regression in rabbits has 
been evaluated by many investigators. Comparison of these 
rabbit studies is difficult due to variations in dietary 
content, duration of dietary administration and the manner of 
atherosclerotic regression evaluation. However, some general 
statements can be made with respect to the effectiveness of 
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removing cholesterol from an atherogenic diet for the 
promotion of atherosclerotic regression: 1) Most studies have 
failed to find evidence for atherosclerotic regression, 2) 
The studies that have found evidence for atherosclerotic 
regression following consumption of an atherogenic diet 
typically had either short periods of cholesterol feeding or 
long periods of cholesterol-free feeding following 
administration of an atherogenic diet, and 3) Regression is 
more frequently observed when treatments are administered to 
supplement the effect of the consumption of a cholesterol-
free diet. 
Friedman and Byers (1958) showed that hypercholesterolemia 
persists after cessation of cholesterol feeding and suggest 
it is due to the discharge of previously accumulated tissue-
cholesterol back into the circulation. They later observed 
(Friedman and Byers 1963) that normal cholesterol 
concentrations were not achieved in less than 5 months after 
discontinuance of dietary cholesterol supplementation, 
consisting of 2% cholesterol. In fact the atherosclerotic 
lesions continued to become more severe during the first 4 
months of the cholesterol-free diet. The atherosclerotic 
process was found to be arrested at the 4 month level when 
rabbits had been fed the cholesterol-free diet for a total of 
9 months. They concluded that regression could not be 
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promoted by dietary modification, but that arrest could be 
achieved when normal plasma cholesterol levels could be re-
achieved. 
The evaluation of regression by Albrect and Schuler (1965) 
is in agreement with the data of Friedman and Byer (1963). 
Albrecht and Schuler (1965) promoted atherosclerosis by 
administering a diet supplemented with 3% cholesterol for 21 
days and showed that, while plasma cholesterol levels 
dropped, the content of cholesterol in the aorta continued to 
rise during the 130-day regression period following the 21 
days of cholesterol feeding. 
Atherosclerotic regression was observed in two other early 
studies that used slightly smaller dietary cholesterol 
supplements. Prior and Ziegler (1965) evaluated regression 
after administration of an atherogenic diet with a slightly 
smaller cholesterol supplement of 1 gram of cholesterol per 
day for 6 months. They noted that approximately 4 months 
were required for rabbits to re-acquire normal plasma 
cholesterol levels. In contrast to both Friedman and Byers 
(1963) and Albrecht and Schuler (1963), they observed that 
regression had occurred in aortas from rabbits killed 6, 10 
and 16 months after cessation of cholesterol feeding, when 
compared to atherosclerotic lesions of rabbits killed 4 
months after cholesterol-supplement cessation. 
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Bortz (1968) administered a 1% cholesterol diet for 14 or 
21 days prior to administration of a cholesterol-free diet. 
Plasma cholesterol levels returned to normal in 5 to 6 weeks 
after a peak of 1,757 mg/dl at the end of the cholesterol 
feeding period. While the aortic cholesterol content 
initially increased after the dietary cholesterol was 
discontinued, rabbits sacrificed at between 50 and 300 days 
after discontinuance had progressively reduced aortic 
cholesterol contents suggesting efflux of tissue cholesterol 
out of aortic lesions. Similar results were observed by 
Gupta, Tandon and Ramalingaswmi (1970), who fed 2 grams 
cholesterol/day to rabbits for 6 months and found that 
regression was not observed until 6 months after cessation of 
cholesterol administration. 
Additional recent studies have continued to evaluate 
atherosclerotic regression in rabbits (Adams et al. 1973; 
Vesselinovitch et al. 1974; Roach and Fletcher 1979; Dudrick 
1987; Jayakody et al. 1989; Kappogoda et al. 1990; Badimon et 
al. 1990; Zhu et al. 1992) and provide additional examples of 
evidence both for and against atherosclerotic regression. 
These atherosclerotic regression studies are reviewed in 
Table 1. An additional review compiled from the data shown 
in Table 1 is compiled in Figure 2. Clearly many of the 
observations outlined in Table 1 are conflicting, but 
generally one observes that, in studies where the regression 
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Table 1. Comparison of rabbit cholesterol-feeding studies 
with respect to the evaluation of atherosclerotic 
regression. 
Days of Days of Regression 
Content of diet CH Feeding Regression' Demonstrated?® Reference 
(Yes or No) 
Chow with 0.3% CH 70 70 No Zhu et al. (1992) 
Chow with 0,5% CH 60 30 No Badimon, Badimon and 
Fuster (1990) 
Chow with 1 % CH 84 365 No Adams, Morgan and 
Bayliss (1973) 
Chow with 2% CH 126 42 No Dudrick (1987) 
Chow with 2% CH 84 112 No Frideman and Byers 
84 252 No (1963) 
Chow with 2.5% CH 21 21 No Kappagoda, Thomson 
21 49 No and Senaratne (1990) 
21 115 Yes 
Chow with 3% CH 21 29 No Albrecht and Schuler 
21 60 No (1965) 
21 130 No 
Chow with 2% CH 42 252 No Jayakody et al. (1989) 
and 24% lipids 
Chow with 2% CH 28 14 No Roach and Fletcher 
and 6% com oil 28 28 Yes (1979) 
28 42 Yes 
0.4 grams CH/rabbit 98 70 No Vesselinovitch et al. 
administered biweekly (1974) 
1 gram CH/day 180 30 No Prior and Ziegler (1965) 
180 60 No 
180 90 No 
180 120 No 
180 180 Yes 
180 300 Yes 
180 480 Yes 
2 grams CH/day 56 70 No Gupta, Tandon and 
56 140 Yes Ramalingswami (1970) 
4* Cholesterol is abbreviated as CH. 
'Period during which cholesterol and/or lipid supplements were discontinued. 
'Author(s) claimed that atherosclerotic regression had been observed (Yes). 
Author(s) claimed that atherosclerotic regression was not observed (No). 
Figure 2. Comparison of the rabbit atherosclerotic regression 
studies listed in (Table 1) with respect to cholesterol-feeding 
period, the duration of the following cholesterol free period 
and study outcome. Open triangles indicate that regression was 
not observed for the given combination of cholesterol-feeding 
days and cholesterol-free days; closed triangle indicates that 
regression was observed. 
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period was very long and/or where the cholesterol 
supplementation was at low levels or maintained for a short 
time, evidence for atherosclerotic regression is more 
frequently documented. 
Hyperoxia has been shown to greatly stimulate 
atherosclerotic regression in rabbits placed onto a 
cholesterol-free diet. Vesselinovitch et al. (1974) fed a 
cholesterol-rich diet for 14 weeks before 10 weeks of a 
cholesterol-free diet. They observed that rabbit groups 
receiving just the cholesterol-free diet did not show 
evidence of regression. However, they observed that groups 
receiving 100% oxygen for 2 hours per day, as part of the 
regressive diet did show atherosclerotic regression in both 
the aorta and coronary arteries. 
The process of atherosclerotic regression in rabbits was 
recently confirmed by Badimon et al. (1990) who administered 
a diet consisting of 0.5% cholesterol for 60 days when one 
group was sacrificed for reference and the remaining rabbits 
were divided into two groups for the next 30 days. Group one 
received the atherogenic diet alone. The other received the 
atherogenic diet and weekly administrations of a HDL-VHDL 
fraction collected from donor rabbits. After 30 days of HDL-
VHDL administration, rabbits receiving the lipoprotein 
supplements had significantly fewer aortic fatty streaks than 
rabbits examined at 60 days or rabbits maintained on the 
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cholesterol diet for the full 90 days. The study proposed 
that the HDL-VHDL fraction was responsible for promoting 
cholesterol efflux away from arterial walls to the liver and 
out of the body in bile. 
The lipid lowering agent lovastatin has also been shown to 
promote the regression of atherosclerotic lesions in rabbits 
(Zhu et al. 1992). A 0.3% cholesterol was administered to 
their rabbits for 10 weeks. For the next 10 weeks, the three 
study groups received a cholesterol-free diet, or a 
cholesterol-free diet in addition to a daily administration 
of either 10 or 20 mg lovastatin/day. Atherosclerotic 
severity progressed in rabbits receiving only the 
cholesterol-free diet but regressed in both groups receiving 
lovastatin. 
Given the prevalence of heart disease as the number one 
killer of Americans today, there is tremendous interest in 
finding new agents that will decrease the rate at which 
atherosclerosis progresses or promote the regression of 
atherosclerosis in people. The preceding discussion will 
demonstrate how dietary ethanol represents an agent with 
potential to affect the atherosclerotic process. In humans, 
the risk of coronary heart disease is reduced in people who 
drink moderate amounts of alcoholic beverages. It has been 
proposed that ethanol does this by increasing the level of 
plasma HDL-cholesterol and by reducing plasma LDL-
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cholesterol. However, studies of ethanol consumption of the 
regression of human atherosclerosis do not exist, in 
addition, the influence of ethanol on atherosclerotic 
regression in an animal model has not been evaluated. 
Potential of Dietary Ethanol as a Therapeutic Agent for 
the Treatment of Atherosclerosis 
Epidemiological studies have proven that moderate consumption 
of ethanol reduces the risk of developing heart disease 
Ethanol has been a part of the human diet for thousands of 
years, yet only recently has it been recognized by the 
scientific community that drinkers develop heart disease less 
frequently. As Eberhard stated in 1936: 
"There has been an impression among pathologists for 
many years that confirmed drunkards do not show as 
much arteriosclerosis for given age groups as do 
temperate persons". 
This literature review will first seek to confirm that 
ethanol consumption is a protective agent against coronary 
43 
heart disease in humans and animal models, then survey the 
possible mechanisms providing protection and finally present 
a hypothesis about how ethanol consumption might also promote 
regression of atherosclerotic lesions. 
The Framingham study of Friedman and Kimball (1986) 
represents one of the earliest studies of human ethanol 
consumption and coronary heart disease. The study utilized a 
population (n=4,745) from the Framingham Heart Study Cohort. 
Their study showed that coronary heart disease mortality 
followed a U-shaped curve with respect to non-smokers and 
ethanol consumption. For females coronary heart disease was 
lowest in those drinking 2-3 ounces/week and higher in non-
drinkers and those drinking more than 2-3 ounces/week. In 
males coronary heart disease was lowest in those drinking 8 
to 19 ounces of ethanol/week. 
Friedman and Kimball's 1986 study has been validated by 
additional recent studies. The study of Rimm et al. (1991) 
used 51,529 male health professionals adjusted for people 
abstaining from ethanol because of pre-existing disease 
conditions. The study determined that "...increasing alcohol 
intake was inversely related to coronary disease 
incidence..." (P<0.001). Klatsky et al. (1992) studied 
128,934 subjects and showed that people drinking 1 to 2 
drinks per day had the lowest risk of coronary disease 
mortality. 
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Correlation of alcoholic beverage type to protection from 
coronary heart disease was evaluated by Friedman and Kimball 
(1986), who found that beer and wine provided approximately 
even and slightly better protection than hard liquor spirits. 
Their results contrast with those of Rimm et al. (1991) who 
found the strongest inverse correlation between ethanol 
consumption and coronary heart disease among drinkers of hard 
liquor spirits. In the study of Klatsky et al. (1992) heart 
disease mortality was found to be the greatest, intermediate 
and least in populations drinking beer, hard liquor and wine, 
respectively. When wine drinkers were evaluated, they found 
that those who drank red wine had the least risk. 
The * French Paradox' is a recently proposed theory (Renaud 
and De Lorgeril 1992) that supports the conclusions of 
Klatsky et al. (1992) in regards to red wine as the most 
effective agent for protection from coronary heart disease. 
The French people have a diet rich in coronary risk factors 
like cholesterol and saturated fats and tend to have 
relatively high plasma cholesterol levels, but when compared 
to Americans and the British, the French have less than half 
to a third the rate of mortality from coronary heart disease. 
Renaud and De Lorgeril (1992) suggest that the reason the 
French are protected is not just that they drink ethanol, but 
because they drink most of their ethanol in the form of red 
wine. 
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Animal studies of the relationship of ethanol consumption to 
atherosclerosis and coronary heart disease 
Epidemiological studies suggest that dietary ethanol 
reduces the establishment of atherosclerosis and heart 
disease, but human experiments to test this hypothesis have 
been difficult because of the length of time needed to look 
for changes in a slow disease process like atherosclerosis 
and because of ethical as well as legal implications 
surrounding ethanol consumption and alcoholism. However, the 
long-term effects of dietary ethanol on non-human primate-
atherosclerosis have been examined by the studies of Rudel et 
al. (1981) and Karsensty et al. (1985). 
Rudel et al. (1981) fed monkeys (Macaca nemestrinal liquid 
diets containing 0.3 or 1.0 mg cholesterol/kcal and 36% of 
the daily caloric intake as either ethanol or a carbohydrate 
substitute in a 2X2 factorial design for 18 months before the 
atherosclerotic severity was evaluated. It was determined 
that dietary ethanol inhibited atherosclerotic development. 
In a similar study by Karsenty et al. (1985), baboons were 
fed cholesterol-enriched diets for one to nine years, 
receiving 50% of dietary calories as ethanol or carbohydrate. 
Although atherosclerotic severity was not directly evaluated, 
they concluded that ethanol consumption promoted an increase 
in cholesterol excretion by the liver as well as changes in 
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the plasma lipoproteins, consistent with providing the 
protection from atherosclerotic development observed by Rudel 
et al. (1981). 
The effects of ethanol administration on experimental 
atherosclerosis in rabbits have been evaluated by several 
studies. Among the earliest was that of Eberhard (1936) who 
administered 0.5 grams of cholesterol/day to rabbits 
receiving either water or ethanol (25% v/v) in drinking water 
and evaluated atherosclerotic progression at periods of up to 
120 days. It was demonstrated that ethanol administration 
resulted in reduced deposition of cholesterol in the aorta. 
In contrast, Kritchevsky and Moyer (1960) were unable to 
show that administration of a 9.5% ethanol solution in 
drinking water could inhibit atherosclerotic development in 
rabbits fed a diet containing 3% cholesterol and 6% corn oil. 
However, their negative result could be due to the extremely 
large amount of cholesterol administered. 
More recently the ethanol-induced inhibition of 
atherosclerotic development observed by Eberhard (1936) was 
confirmed by the rabbit studies of Goto et al. (1974) and 
Klurfeld and Kritchevsky (1981). Goto et al. (1974) fed 
rabbits a diet consisting of 0.5% cholesterol and 5% lard for 
between 134 and 139 days; during this time, rabbits received 
water or water containing either 5% or 10% ethanol. The 
rabbits receiving water had aortas with 24.4 ± 5.4% of their 
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aortas covered by atherosclerotic lesions, aortas from 
rabbits receiving 5% ethanol had aortas covered by 9.9 ± 1.9% 
covered by lesions; this was significantly less than the 
water fed rabbits (P < 0.05). Rabbits consuming 10% ethanol 
were even less affected, having aorta covered by only 5.5 ± 
2.4% (P < 0.05) . 
Correlation of beverage type to protection from 
atherosclerotic development to inhibition was evaluated by 
Klurfeld and Kritchevsky (1981). An earlier investigation by 
Kritchevsky and Moyer (1960) used a diet with 3% cholesterol 
with 6% corn oil with or without 9.5% ethanol and concluded 
that ethanol did not inhibit atherosclerotic progression. 
Klurfeld and Kritchevsky (1981) used a smaller dietary 
cholesterol supplement (0.5%) and compared several beverage 
types (ethanol in water, red wine, white wine, beer, whiskey) 
adjusted with ethanol to a final ethanol content of 9.5% 
against water with a isocaloric glucose supplement for the 
inhibition of atherosclerotic development. In their study 
atherosclerotic severity was expressed as percent Sudan~IV 
staining area as a percentage of the total aortic surface 
area. Red wine significantly inhibited atherosclerotic 
development when compared to rabbits receiving just glucose 
in water (P<0.05). Where as rabbits consuming ethanol, white 
wine, whiskey and beer did not developed statistically 
significant differences in atherosclerotic development. 
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Because red wine was found to be the most effective inhibitor 
of atherosclerosis, the results of Klurfeld and Kritchevsky 
(1981) confirm the French Paradox suggested by Renaud and De 
Lorgeril (1992). 
The influence of ethanol on pathways of cholesterol transport 
and atherosclerotic development 
When compared to men who do no drink alcoholic beverages, 
consumption of dietary ethanol (5-6 ounces/week) by men has 
been found to promote a 10 percent increase in plasma HDL-
cholesterol and a 10 percent decrease in plasma LDL-
cholesterol (Castelli et al. 1977) . The increase in HDL-
cholesterol and the decrease in LDL-cholesterol are 
responsible for approximately 50% (HDL) and 17% (LDL) of the 
protection from coronary heart disease associated with 
ethanol consumption (Langer et al. 1992). After cessation of 
ethanol consumption for two to three weeks the healthy 
changes in the lipoprotein profile disappear (Taskinen et al. 
1982). How ethanol causes HDL-cholesterol to increase and 
LDL-cholesterol to decrease is still not understood. 
HDL particles are responsible for transporting cholesterol 
away from the periphery and to the liver, where it may be 
removed from the body in bile or recycled into VLDL 
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particles. Cholesterol ester transfer protein provides 
cholesterol esters within HDL particles with an opportunity 
to return to atherogenic LDL and VLDL particles before the 
HDL particle and the cholesterol esters within it can be 
removed by the liver (Tall 1990). It has been observed that 
CETP activity in alcoholics is very low (Savolainen et al. 
1990) and that the increase in HDL-cholesterol in alcoholics 
could be due to an decrease in both the plasma CETP activity 
and concentration, effects that are reversible with 
abstention from ethanol (Hannuksela et al. 1992). 
Ethanol consumption may also affect the HDL-cholesterol 
concentration by acting on apolipoprotein A-I and LCAT. Apo 
A-I is the primary activator of LCAT in the plasma, and LCAT 
serves to esterify free cholesterol in HDL particles (Jonas 
1991). The activity of apo A-I and LCAT maintains a 
concentration gradient for diffusion of free cholesterol from 
the cell membranes of peripheral cells into HDL particles 
(Jonas 1991). Because ethanol consumption increases both the 
activity and the rate of Apo A-I (Camargo et al. 1985; 
Amarasuriya et al. 1992), ethanol apparently increases the 
rate of cholesterol esterification within the HDL particle 
and promotes the maintenance of a concentration gradient 
responsible for removal of free-cholesterol from peripheral 
cell membranes to the HDL particle. Ethanol consumption 
appears to promote the uptake of peripheral cholesterol from 
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sites like an atherosclerotic plaque and prevent the 
cholesterol from being redeposited into VLDL and LDL 
particles, and ultimately into atherosclerotic plaques. 
The reduction in plasma LDL-cholesterol associated with 
ethanol consumption has been difficult to explain. It is 
possible that by inhibiting CETP, ethanol inhibits the entry 
of HDL-bound cholesterol esters into LDL particles. 
Evaluation of this problem is further complicated by the fact 
that ethanol consumption increases both the rate of VLDL 
synthesis by the liver (Savolainen et al. 1986) and the 
content of triglycerides in VLDL particles, and to a lesser 
extent LDL and HDL particles as well (Schneider et al. 1985). 
Paradoxically, the concentration of the catabolic product 
of VLDL metabolism, the LDL particle is decreased by ethanol 
consumption. This paradox has been recently examined by Wehr 
et al. (1993), who suggest that acetaldehyde, the metabolic 
product of ethanol, forms adducts with apo-B containing 
particles, increasing the rate of their uptake from the 
circulation. By this mechanism, even though VLDL synthesis 
is increased and more LDL particles are produced as a result 
of VLDL degradation, an increase in LDL uptake due to the 
modification is great enough to lower the total LDL-
cholesterol concentration. This hypothesis is intriguing and 
awaits confirmation, but is potentially flawed because 
factors which increase LDL uptake, like oxidative 
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modification promote the atherogenic process, where as 
ethanol consumption inhibits the process. 
In contrast to the previously described beneficial effects 
of ethanol, the effects of ethanol on the formation of EDRF 
represent an example of how ethanol may not be beneficial in 
cases of heart disease. It has recently been shown that 
ethanol inhibits the formation of endothelially-dependent 
relaxing factor and arterial relaxation (Persson and 
Gustafsson 1992; Hatake et al. 1993). These recent 
observations may help explain why ethanol infusion results in 
contraction of canine epicardial arteries (Hayes and Bove 
1988; Rogers and Bove 1989). Furthermore, a reduction in 
EDRF formation can promote conditions in the arterial wall 
favoring promotion of the atherosclerotic process. 
Clearly, ethanol has both potential health benefits and 
risks in regards to heart disease and atherosclerosis. But 
ultimately clinical studies have overwhelmingly shown that 
ethanol consumption is correlated with a reduction in both 
the incidence and mortality of coronary heart disease. Given 
that heart disease is the greatest single killer of people of 
industrialized nations, ethanol must be considered beneficial 
in regards to its effect on human health. 
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Can ethanol consumption promote the regression of previously 
established atherosclerotic lesions? 
As previously reviewed in this literature review, 
investigators have determined that consumption of ethanol 
inhibits the development of atherosclerosis in humans, non-
human primates and rabbits. Whether ethanol consumption 
could promote the regression of atherosclerotic lesions 
established prior to inclusion of ethanol in the diet has not 
been examined at either the clinical or the experimental 
level on humans or animals. There are several reasons to 
believe that ethanol could have potential as a therapeutic 
agent promoting regression of previously established 
atherosclerotic disease. 
Ethanol-induced changes in the lipoprotein profile favor 
reverse cholesterol transport out of peripheral sites, like 
atherosclerotic plaques. Epidemiologically, individuals with 
high HDL-cholesterol have a very low incidence of 
atherosclerosis and the infusion of additional HDL particles 
promote the regression of atherosclerotic plaques in rabbits 
(Badimon et al. 1990). Because HDL-cholesterol 
concentrations increase as a result of ethanol consumption, 
ethanol may promote increased transport from places like 
atherosclerotic plaques to the liver for removal from the 
body, thus promoting atherosclerotic regression. 
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Ethanol consumption might also promote atherosclerotic 
regression by reducing the delivery of cholesterol to 
peripheral sites like atherosclerotic plaques and the LDL-
cholesterol concentration. Given that cholesterol is in a 
constant state of flux in and out of macrophage derived foam 
cells (Brown et al. 1980), any reduction in the transport of 
cholesterol into a lesion would have potential to increase 
the net effect of cholesterol efflux and promote a reduction 
in the cholesterol mass of the plaque and the ultimate lesion 
size. 
The activity and secretion of several enzymes from the 
liver is also modified by ethanol in a manner that should 
promote regression of atherosclerotic plaques. Ethanol 
associated increases in apo A-I secretion and activity would 
also help prevent cholesterol recirculation into VLDL and LDL 
particles by promoting faster esterification of free-
cholesterol associated with HDL particles and sequestration 
of cholesterol esters to the center of HDL particles. By 
inhibiting CETP, ethanol prevents cholesterol from being 
recycled into lipoproteins that deposit cholesterol in the 
periphery, reducing the rate of cholesterol deposition into 
the periphery. 
Ethanol might also decrease the stimulus for continued 
plaque growth by acting on platelets. Activated platelets 
release factors like platelet derived growth factor and 
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serotonin that increase LDL permeability, LDL oxidation, LDL 
uptake and smooth muscle proliferation. Because ethanol 
inhibits platelet aggregation, ethanol consumption might 
reduce the stimuli for additional atherosclerotic plaque 
growth, thereby increasing the relative influence of factors 
promoting efflux of cholesterol out of atherosclerotic 
plagues. 
Dissertation Hypothesis 
The effect of dietary ethanol on previously established 
atherosclerotic disease has never been addressed by either 
human or animal studies. Given that ethanol consumption 
promotes anti-atherogenic changes in cholesterol metabolism, 
enzyme activities and atherogenic stimuli, it is the proposal 
of this dissertation that the consumption of ethanol will 
promote the regression of previously established 
atherosclerotic lesions. Furthermore, because the 
atherosclerotic process is similar in the man and rabbit, 
this dissertation proposes to use atherosclerotic rabbits as 
a model for the effects of ethanol on atherosclerotic people. 
The research described in this dissertation asks whether 
ethanol consumption can reduce the severity of 
atherosclerotic disease in rabbits by: 
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1) Promoting a healthier lipoprotein-cholesterol profile, 
2) Enhancing cholesterol transport out of atherosclerotic 
lesions, 
3) Reducing the arterial surface area affected by 
atherosclerosis, 
4) Reducing the degree of foam cell infiltration in the 
arterial wall, and 
5) Reducing the vascular constrictive responses to several 
known vasoconstrictive compounds. 
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CHAPTER 3. EFFECT OF DIETARY ETHANOL ON ATHEROSCLEROTIC 
RABBITS CONSUMING A CHOLESTEROL-FREE DIET 
A paper to be submitted for publication in the Journal of 
Comparative Biochemistry and Physiology. 
Edward F. Wilson, Travis Knight, Donald C. Beitz 
and Richard L. Engen 
Abstract 
The effect of dietary ethanol on plasma lipids and 
atherosclerotic regression in atherosclerotic rabbits was 
addressed by feeding 19 male New Zealand white rabbits a diet 
enriched with 0.8% cholesterol for 45 days, followed by 
randomization to one of three diets for the next 45 days: 1) 
Continued consumption of a cholesterol-rich diet (CC; n=6), 
2) Consumption of a cholesterol-free diet (CP; n=6), and 3) 
Consumption of a cholesterol-free diet supplemented with 
ethanol in the drinking water (10% v/v; ECF; n=7). Data are 
expressed as mean ± SEM, means with the same letter are not 
significantly (P < 0.05) different. On day 0, the plasma 
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triglyceride, total-, very low density lipoprotein (VLDL)-, 
low density lipoprotein (LDL)- and high density lipoprotein 
(HDL)-cholesterol concentration (n=19) was 54.93 ± 7.75, 
77.04 ± 15.51, 23.06 ± 5.21, 32.22 ± 10.67 and 21.73 ± 2.3 
mg/dl, respectively. On day 45, the triglyceride, total-, 
VLDL-, LDL-, and HDL-cholesterol concentration was 437.90 ± 
49.17, 2281.7 ± 133.96, 1316.36 ± 56.10, 731.34 ± 63.44 and 
238.62 ± 42.80 mg/dl, respectively. On day 90, the total 
plasma cholesterol concentration of the CC, CF and ECF groups 
was 1532 ± 107.01-^, 440.50 ± 44.08® and 957.79 ± 157.21 
mg/dl^, respectively. On day 90, the plasma very low density 
lipoprotein (VLDL)-cholesterol concentration of the CC, CF 
and ECF groups was 1018.40 ± 79.29'^, 217.40 ± 24.05® and 
597.50 ± 115.36^ mg/dl, respectively. On day 90, the plasma 
low density lipoprotein (LDL)-cholesterol concentration of 
the CC, CF and ECF groups was 483.63 ± 79.29^, 205.18 ± 
39.51® and 312.77 ± 49.93® mg/dl, respectively. On day 90, 
the plasma high density lipoprotein (HDL)-cholesterol 
concentrations of the CC, CF and ECF groups were 46.46 ± 
5.16'^, 17.92 ± 3.54'^ and 47.51 ± 15.95 mg/dl^, respectively. 
On day 90, the plasma triglyceride concentration of the CC, 
CF and ECF groups was 238.97 ± 64.28'^, 79.97 ± 11.77'^ and 
433.32 ± 122.07® mg/dl, respectively. Between days 45 and 
90, the resolution of the developed hyperlipidemia in the CC, 
CF and ECF groups is graded as least, moderate and greatest, 
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respectively. On day 90, no significant differences were 
noted in regards to the percent of aortic surface covered by 
Sudan-IV staining lesions, fatty streak areas in aortic 
cross-sections, smooth muscle area or aortic cholesterol 
content. On day 90, the total liver cholesterol content of 
the CC, CF and ECF groups was 3.98 ± O.SS'^, 2.36 ± 0.30® and 
1.97 ± 0.31® grams cholesterol/liver, respectively. This 
investigation demonstrated that neither the CF nor ECF diets 
promoted atherosclerotic regression, and that plasma lipid 
resolution was only moderate in the ECF group. 
Introduction 
Cholesterol-rich diets are associated with increased 
plasma VLDL- and LDL-cholesterol concentrations which are 
positively correlated with increased atherosclerotic severity 
(Nordesgaard, Tybaerg-Hansen and Lewis, 1992; Adams et al., 
1982). In contrast, increased HDL-cholesterol concentrations 
are negatively correlated with atherosclerotic development 
(Johansson et al., 1991; Gaziano et al., 1993). 
Atherosclerotic severity is a product of increased 
cholesterol deposition into the arterial wall, resulting in 
the formation of cholesterol-rich fatty streaks and plaques 
along the surface of the arterial lumen. As the disease 
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progresses, these lesions cover increased percentages of 
arterial surface area and encroach upon the arterial lumen, 
leading to potential reductions in blood flow (Ross, 1993). 
Primary clinical treatment of high plasma cholesterol and 
atherosclerosis includes a lipid-lowering diet with reduced 
cholesterol content (National Cholesterol Education Program, 
1988) . 
Atherosclerotic regression refers to a reduction in the 
severity of the previously mentioned factors associated with 
increased atherosclerotic severity. Atherosclerotic 
regression in humans and rabbits has been documented in 
association with decreases in VLDL- and LDL-cholesterol 
(Brown et al., 1990; Blankenhorn et al., 1987; Daugherty et 
al., 1986). Furthermore, it has been shown that intravenous 
administration of HDL particles to rabbits can also promote 
atherosclerotic regression by promoting HDL-mediated 
cholesterol efflux (Badimon et al., 1990). 
Eberhard (1936) fed rabbits a crude cholesterol purified 
from gallstones to rabbits with or without a 25% (v/v) 
solution of ethanol and determined that the cholesterol 
content of the rabbits receiving dietary cholesterol was 2.00 
grams of cholesterol per 100 grams dry weight and that the 
aortas removed from rabbits receiving both dietary ethanol 
and cholesterol was less at 1.26 grams of cholesterol per 100 
grams dry weight; however, statistical comparisons were not 
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performed. Goto et al. (1970) maintained rabbits on a diet 
containing 0.5% cholesterol and 5.0 % lard for 13 weeks with 
fluid in the form of water, 5% (v/v) ethanol or 10% (v/v) 
ethanol. After 13 weeks rabbits fed water, 5% ethanol and 
10% ethanol, had Sudan-IV stained lesions covering 24.4%, 
9.9% and 5.5% of the aortic surface areas, respectively. The 
5% ethanol and 10% ethanol groups had significantly less 
lesion area at the P < 0.05 and P < 0.01 levels, 
respectively. More recently Klurfeld and Kritchevsky (1981) 
fed rabbits a diet supplemented with cholesterol (0.5% w/w) 
for 3 months with either water or red wine (10% ethanol v/v). 
Klurfeld and Kritchevsky (1981) found that 34% and 10% of the 
aortic arch was covered with Sudan-IV staining lesions in the 
water and red wine groups, respectively, significance was P < 
0.05 with a t-test. 
The studies of rabbits confirm that atherogenesis in 
rabbits is inhibited by ethanol consumption, the same 
observations have been made in humans. The epidemiological 
study of Friedman and Kimball (1986) demonstrated that in 
human non-smoking males consuming 4 to 7 ounces of ethanol 
per week, over all mortality and mortality from coronary 
heart disease was 48% and 10% less, respectively, than that 
observed in non-smoking males who did not consume ethanol. 
The primary mechanism for the protective effect of ethanol 
consumption is an increase in plasma HDL-cholesterol and 
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cholesterol efflux out of atherosclerotic lesions (Castelli 
et al., 1977; Langer et al., 1992). The mechanisms for 
protection may also include the following: 1) Ethanol 
associated inhibition of cholesteryl ester transfer protein 
(CETP) and decreased transfer of cholesterol from HDL to LDL 
particles (Hannuksela et al., 1992; Savolainen et al., 1990), 
2) Ethanol associated increases in Apo Al secretion and 
activity, resulting in improved cholesterol efflux 
(Amarasuriya et al., 1992; Camargo et al., 1985), and 3) 
Ethanol associated decreases in plasma LDL-cholesterol 
concentration (Castelli et al., 1977; Langer et al., 1992). 
The effect of dietary ethanol on cholesterol metabolism 
and atherosclerosis during administration of a cholesterol-
free diet is unknown. Dietary ethanol has the potential to 
affect atherosclerotic severity because of its effect on HDL-
cholesterol, LDL-cholesterol, CETP and Apo Al. This 
investigation evaluated the effect of dietary ethanol 
administration on atherosclerotic rabbits consuming a 
cholesterol-lowering diet in regards to the promotion of 
atherosclerotic regression. 
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Materials and Methods 
Experimental design: Male New Zealand White rabbits weighing 
1.9 to 3.0 kg were obtained from LSR Inc. Union Grove, 
Wisconsin. Rabbits were obtained as a set of 18, followed by 
an additional set of 5, staggered 45 days behind the set of 
18. Rabbits were fed from a single manufactured lot of 
Teklad #0533 (Madison, Wisconsin) rabbit chow (140 
grams/day). The chow was made atherogenic by adding a 
cholesterol-supplement prepared by dissolving cholesterol in 
butylmethylphenol-free ethyl ether (1 gram/10 ml) and evenly 
dispersing the solution onto the rabbit chow. The ether was 
evaporated from the chow under a fume hood, leaving chow 
enriched with 0.8% cholesterol. 
This atherogenic chow was fed to all rabbits from days 0 
to 45. On day 45, the rabbits were randomized to one of 
three treatments for the next 45 days: 1) Rabbits received 
the same atherogenic rabbit chow (Cholesterol consuming; CC), 
2) Rabbits received chow with no cholesterol supplement 
(Cholesterol-free; CF), and 3) Rabbits received dietary 
ethanol in their drinking fluid (10% ethanol v/v) in addition 
to the cholesterol-free diet (ECF). 
During the course of the experiment the rabbits had free 
access to the following drinking solutions. Water was 
administered between days 5 to 45 to all rabbits. Antibiotic 
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treatment of pneumonia was repeated for all rabbits (days 0 
to 4, days 50 to 58 and days 71 to 80) and consisted of 
tetracycline (2 mg/ml) dissolved in Kool-Aide (0.16% Kool-
Aide; 5% sugar) for improved palatability. The Kool-Aide 
solution was also administered to all rabbits between days 45 
and 90; this solution was supplemented with ethanol (10% 
v/v) for rabbits assigned to the ECF treatment group. Three 
rabbits died of pneumonia during the course of the 
experiment, and one rabbit was euthanized as a result of a 
handling injury; these rabbits were excluded from this 
experiment. 
Blood collection and analysis. During the experiment, blood 
was collected after a 12-hour fast from the central ear 
artery at three different times: 1) On day 0 prior to 
administration of the CC diet, 2) Just prior to dietary 
reassignment on day 45, and 3) On day 90. To promote animal 
sedation, acepromazine (Fort Dodge Laboratories, Fort Dodge, 
Iowa; 0.4 mg/kg) was administered intramuscularly 5 minutes 
prior to collection. Blood was collected from the central 
ear artery with a 21 gauge butterfly catheter and mixed with 
disodium EDTA (2 mg/ml) to prevent clotting. After being 
placed on ice, the packed cell volume of the raw blood was 
determined by centrifugation. The remaining blood was then 
centrifuged for 15 minutes (650 x g) and the plasma removed. 
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A 2.5-ial portion of the plasma was used for lipoprotein 
determination, and the remainder was frozen (-20°C) for 
plasma triglyceride determination at a later time. 
Plasma lipoproteins were separated with 
ultracentrifugation on the basis of density by using the 
method of Havel et al. (1955). Lipoprotein separation was 
performed on 2.5 ml of plasma mixed thoroughly with 0.5 ml of 
0.9% NaCl. Lipoproteins were separated into density 
gradients of less than 1.005 g/ml, 1.005 to 1.063 g/ml and 
1.063 to 1.210 g/ml, representing the VLDL, LDL and HDL 
fractions, respectively. The lipoprotein fractions were 
collected into cryovials and frozen at -20°C. 
After the lipoprotein and raw plasma samples had been 
thawed, the plasma triglyceride concentration and the 
cholesterol content of each lipoprotein fraction was 
determined by using enzymatic test kits from Stanbio Inc. 
(San Antonio, Texas). The samples were diluted as needed to 
bring the sample concentrations into the concentration range 
of 1 to 200 mg/dl, a concentration range in which the 
colorimetric assay was known to function in a linear fashion. 
All samples were referenced to a 200 mg/dl certified 
reference standard (Stanbio Inc., San Antonio Texas). 
Evaluation of atherosclerosis. On day 90, and after being 
bled, the rabbits were returned to their cages preserving 
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their respective diet for at least 3 hours. Then, following 
a 2- to 3-hour secondary fast from food and fluids, 
pentobarbital (40 mg/kg) was administered into the ear vein. 
Anesthetized rabbits were decapitated and bled to facilitate 
organ removal. The aorta was gently dissected starting 3 mm 
distal to the aortic valve and running distally to the iliac 
bifurcation. 
Lipophilic deposits on the surface of the arterial lumen 
of two aortic segments from each rabbit were stained by using 
the Sudan-IV staining method of Holman et al. (1958). The 
first segment consisted of tissue that started 37 mm distal 
from the aortic valve and stopped at the renal artery; the 
second segment started 25 mm distal of the renal artery and 
ended at the iliac bifurcation. The fresh segments were slit 
lengthwise, opened flat and pinned in this position prior to 
immersion in 10% formalin (pH 7.3) and fixed for 24 hours. 
Fixed tissues were removed, rinsed briefly with 70% (v/v) 
ethanol and immersed in the staining solution (5 g Sudan-IV, 
500 ml acetone and 500 ml ethanol) for 15 minutes prior to 
rinsing with 80% ethanol. After differentiating the stain in 
a 80% ethanol bath for 20 minutes, the segments were washed 
in cold tap water and stored in 5% formalin at 4°C until 
color photographed. 
Computer images of the aortic segments were acquired from 
the photographs by using a Zeiss SEM-IPS image analysis 
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system (Roche Inc., Elan College, North Carolina; IBAS 
version 2.00). Images were captured with a Sony DXC-3000A 3 
CCD color video camera (Sony Inc., San Diego, California) 
calibrated to a scale measuring in millimeters, normalized 
and shade corrected. The stained area on each segment was 
discriminated from a computer generated color plane and the 
total area of Sudan-IV staining area was calculated as the 
percent of the total surface area by using a computer program 
(Image Analysis Facility, Iowa State University). All aortic 
segments were processed in one session by one person with the 
tissues re-numbered so that the operator would not know how 
the tissues were assigned to treatments. 
Histological features of the aorta were evaluated by using 
aortic rings (2 mm long) removed at a location starting 3 mm 
distal from the aortic valve and at a position starting 
another 30 mm distally. The rings were washed and 
immediately placed in a 10% formalin solution (pH 7.3), prior 
to embedding in paraffin wax. Thin sections from the center 
of the embedded segments were cut and stained with 
hematoxylin and eosin (Histology Laboratory, Department of 
Pathology, Iowa State University). 
Images of the aortic cross-sections were captured with a 
Sony DXC-3000A3 CCD color video camera and digitalized with a 
Zeiss SEM-IPS image analysis system (Zeiss-Kontron; IBAS 
version 2.00) and then computer-scaled to measure in 
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millimeters. Captured images were then shade corrected and 
normalized. The tissues were given new identification 
numbers so that the operator would not know how the tissues 
were assigned to treatments, the area of vascular smooth 
muscle and fatty streak visible in each section was then 
outlined and calculated by using computer software prepared 
by the Image Analysis Facility of Iowa State University. The 
areas of smooth muscle and fatty streak in the two rings were 
then added together and divided by two, generating average 
cross-sectional values for each animal. 
A section of aortic tissue starting at the renal arteries 
and ending 25 mm distally was used in a study described 
separately in Chapter 4. 
Tissue cholesterol determination. The cholesterol content of 
each liver was determined by first using the lipid extraction 
method of Bligh and Dyer (1959). The livers were combined 
with 50 ml HjO and homogenized with Tekmar tissue 
homogenizer. A 250-)ul sample from the homogenate was 
vortexed for 60 seconds in 8.32 ml of a 
chloroform;methanol:water solution (1:2:0.8; v:v:v) and 
shaken overnight. Then, 2.5 ml of chloroform and 2.5 ml of 
KCl (0.37%) was added prior to 10 seconds of vortexing. The 
sample was centrifuged for 20 minutes (650 X g) and the top 
layer removed. Then, 3.33 ml KCl (0.37%) was added and the 
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solution was vortexed for 10 seconds and centrifuged (650 x 
g) for 15 minutes. The top layer was removed and 3.33 ml KCl 
(0.37%) was added, prior to 10 seconds of vortexing and 15 
minutes of centrifugation (650 x g). The top layer was 
removed and the extract was filtered through glass wool into 
a scintillation vial. Then Nj gas was blown over the extract 
until dry. After Nj gas treatment, isopropanol was added to 
re-solubilized the lipids for enzymatic determination of 
tissue cholesterol content as previously described for the 
plasma samples. Liver cholesterol was expressed as grams of 
cholesterol per liver and milligrams of cholesterol per gram 
of wet weight liver. 
The 3 0-mm long segment located at the arch of the aorta 
was used for a tissue cholesterol assay. After collection, 
the adventitial tissue was removed. Then the segment was cut 
lengthwise and visually inspected for atherosclerotic 
deposits. After visual inspection, each segment was weighed 
and frozen at -20°C until lipid extraction could be 
performed. The aortic segments were finely minced prior to 
vortexing for 60 seconds in 8.32 ml of a 
chloroform:methanol;water solution (1:2:0.8; v:v:v) and 
shaken for six hours for lipid extraction. Extraction was 
then completed exactly as for the liver. Aortic cholesterol 
content was then expressed on a per segment basis and on a 
per gram of wet weight tissue. 
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Statistical Analysis. Data are presented as the mean ± the 
standard error of the mean (SEM). When group differences 
were detected by the analysis of variance, Duncan's Multiple 
Comparison test was used to test for significant differences 
(P<0.05) between individual group means. 
The Student's t-test was used to assess the significance 
of time dependent changes in the plasma lipid concentrations, 
the result of these tests are found and discussed separately 
in Appendix 1. 
Results 
Weight gain by the three groups of rabbits was similar 
throughout the 90-day period (Table 1). The rate of food 
consumption (Table 2) after day 45 was similar for the three 
groups. The rate of fluid consumption after dietary 
reassignment is shown in Table 3. The rabbits in the CF 
group drank significantly more fluid at all intervals than 
did the rabbits in the CC and ECF groups (t-test; P < 0.05). 
On day 90, significant differences between the three groups 
were not detected in regards to the percent packed cell 
volume, aortic arch segment weight, liver weight and lung 
weight (Table 4); in addition, signs of pneumonia were not 
observed in any lungs on day 90. 
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Table 1. Body weights (kg) recorded at five-day intervals 
during the 90 day experimental observation period. 
Data are represented as mean ± SEM. 
^ * Group 
Day 0 Day 5 
Animal Weight 
Day 10 Day 15 Day 20 
CC 2.30 ± 0.10 2.55 ± 0.09 2.81 ± 0.11 2.77 ± 0.04 2.85 ± 0.04 
CF 2.57 ± 0.16 2.86 ± 0.10 2.96 ±0.11 3.01 ± 0.08 3.07 ± 0.09 
ECF 2.55 ± 0.12 2.87 ± 0.09 3.07 ± 0.08 3.02 ± 0.08 3.09 ± 0.08 
Day 25 Day 30 Day 35 Day 40 Day 45 
CC 3.13 ± 0.07 3.24 ± 0.06 3.27 ± 0.07 3.34 ± 0.07 3.44 ± 0.09 
CF 3.25 ± 0.07 3.43 ± 0.06 3.38 ± 0.09 3.49 ± 0.06 3.44 ± 0.06 
ECF 3.32 ± 0.05 3.38 ± 0.16 3.48 ± 0.06 3.56 ± 0.05 3.62 ± 0.10 
Day 50 Day 55 Day 60 Day 65 Day 70 
CC no data 3.48 ± 0.07 3.39 ± 0.08 3.49 ± 0.05 3.51 ± 0.07 
CF no data 3.60 ± 0.13 3.65 ± 0.09 3.65 ± 0.08 3.56 ± 0.08 
ECF no data 3.58 ± 0.12 3.69 ± 0.14 3.70 ± 0.09 3.82 ± 0.10 
Day 75 Day 80 Day 85 Day 90 
CC 3.44 ± 0.13 3.43 ±0.11 3.48 ±0.11 3.52 ± 0.14 
CF 3.57 ± 0.12 3.57 ± 0.12 3.66 ± 0.11 3.74 ± 0.14 
ECF 3.67 ± 0.12 3.81 ± 0.13 3.77 ± 0.10 3.82 ± 0.11 
*Treatment Groups: Cholesterol consuming (CC; n=6), Cholesterol-free (CF; n=6) and 
Ethanol-consuming and cholesterol-ftee (ECF; n=7). 
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Table 2. Food consumption measured as the average of five-
day intervals between days 55 and 85. Data are 
represented as mean ± SEM. 
Food Consumption (g/kg • dav) 
Treatment Group* 
CC (n=6) CF (n=6) ECF (n=7) 
55 28.2 ± 2.7 27.7 ± 2.3 21.1 ± 2.0 
60 27.5 ± 4.6 24.1 ± 2.0 21.6 ± 1.1 
65 26.0 ± 1.4 26.3 ± 2.8 23.6 ± 1.1 
70 23.9 ± 2.4 25.7 ± 1.5 22.0 ± 1.9 
75 20.9 ± 2.2 25.3 ± 1.7 21.1 ± 1,9 
80 22.4 ± 2.8 25.8 ± 1.2 19.5 ± 1.4 
85 25.8 ± 1.1 27.2 ± 2.4 19.1 ± 1.3 
Treatment Groups: Cliolesterol consuming (CC), Cholesterol-free (CF) and Ethanol-
consuming and cholesterol-free (ECF). 
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Table 3. Fluid consumption measured as the average of five-
day intervals between days 55 and 85. Data are 
represented as mean ± SEM. 
Fluid Consumption Cml/kp-dav") 
Day Treatment Group* 
CC (n=6) CF (n=6) ECF (n=7) 
55 48.0 ± 6.7 66.4 ± 1.0 38.7 ± 3,5 
60 48.7 ± 7.3 67.4 ± 3.7 44.8 ± 3.5 
65 41.9 ± 5.0 65.7 ± 1.7 44.9 ± 2.3 
70 44.8 ± 4.5 71.9 ± 4.5 44.4 ± 2.0 
75 37.5 ± 5.1 63.0 ± 2.1 44.2 ± 3.1 
80 33.9 ± 2.2 63.6 ± 4.2 37.7 ± 2.4 
85 42.5 ± 8.9 65.7 + 2.5 33.2 ± 3.7 
9|e 
Treatment Groups: Cholesterol consuming (CC), Cholesterol-free (CF) and Ethanol-
consuming and cholesterol-free (ECF). At all times rabbits in the CF group drank 
significantly more fluid/kg • day than did animals in teh CC and ECF groups (Student's t-
test; P<0.05). 
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Table 4. Hematocrit and organ weights collected on day 90. 
Treatment Group 
Variable* CC (n=6) CF (n=6) ECF (n=7) 
Hematocrit (%) 30.42 ± 1.32 37.55 ± 1.28 38.76 ± 3.26 
Aorta Wt (mg) 393.33 ± 50.02 359.33 ± 18.87 332.43 ± 18.87 
Liver Wt (g) 123.55 ± 2.52 139.33 ± 13.71 132.47 ± 7.86 
Lung Wt (g) 14.55 ±1.12 16.12 ± 1.47 17.86 ± 1.52 
Treatment Groups; Cholesterol consuming (CC), Cholesterol-free (CF) and Ethanol-consuming 
and cholesterol-free (ECF). 
*Data expressed as mean ± SEM; no significant differences (P< 0.05) detected between 
groups. 
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On day 0, the plasma triglyceride, total-, VLDL-, low 
density lipoprotein (LDL)- and HDL-cholesterol concentration 
(n=19) was 54.93 ± 7.75, 77.04 ± 15.51, 23.06 ± 5.21, 32.22 ± 
10.67 and 21.73 ± 2.3 mg/dl, respectively. On day 45, the 
plasma triglyceride, total-, VLDL-, LDL-, and HDL-cholesterol 
concentration was 437.90 ± 49.17, 2281.7 ± 133.96, 1316.36 ± 
56.10, 731.34 ± 63.44 and 238.62 ± 42.80 mg/dl, respectively. 
Plasma triglyceride concentration was modified by dietary 
assignment (Table 5). Compared to day 0 values, all three 
groups had greater amounts of plasma triglycerides after 
consuming the cholesterol-rich diet for 45 days. During the 
period of 46 to 90 days, hypertriglyceridemia was maintained 
in the CC and ECF animals; but by day 90, the 
triglyceride concentration of the CF group had returned to 
near the day 0 concentration. Statistical comparison of the 
three groups on day 90 showed that the ECF group had a 
significantly greater plasma triglyceride concentration 
(P < 0.05) than did the CF group and that the CC group also 
had significantly more (P < 0.05) plasma triglycerides than 
did the CF group. 
On day 90, the CC group had significantly (P < 0.05) more 
total cholesterol than did any other group and the CF group 
had significantly less (P < 0.05) total cholesterol than did 
any other group (Table 6). Diet effects on the VLDL-
cholesterol concentration (Table 7) and the LDL-cholesterol 
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Table 5. Plasma triglyceride concentrations on day 0, 45 
and 90. 
Triglycerides (mg/dl; mean ± SEM) 
Day Treatment Group 
CC CF ECF 
0 46.81 ± 13.12 66.45 ± 18.43 50.87 ± 9.15 
45 367.54 ± 67.25 402.52 ± 76.52 528.56 ± 100.08 
90* 238.97 ± 64.28^ 79.97 ± 11.77^ 433.32 ± 122.07B 
4: 
Treatment Groups: Cholesterol consuming (CC; n=6), Cholesterol-free (CF, n=6) and 
Ethanol-consuming and cholesterol-free (ECF, n=7). 
Tor the CC group, n=5 at day 0. 
^Statistically significant (P < 0.05) differences between groups, means with same letter are not 
significantly different. 
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Table 6. Total plasma cholesterol on day 0, 45 and 90, 
expressed as the sum of the VLDL-, LDL- and HDL' 
cholesterol concentrations. 
Total cholesterol (mg/dl; mean ± SEM) 
Day Treatment Group 
CC CF ECF 
0 125.14 ± 32.90^ 43.00 ± 4.23 71.77 ± 27.90 
45 2307.88 ± 295.49 2353.56 ± 232.89 2288.56 ± 231.98 
90* 1532.82 ± 107.01^ 440.50 ± 44.08® 957.79 ± 157.21'^ 
4: 
Treatment Groups: Cholesterol consuming (CC; n=6), Cholesterol-free (CF, n=6) and 
Ethanol-consuming and cholesterol-free (ECF, n=7). 
'For the CC group, n=5 at day 0. 
^Statistically significant (P < 0.05) differences between groups, means with same letter are not 
significantly different. 
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Table 7. Plasma VLDL-cholesterol concentration on day 0, 45 
and 90. 
Cholesterol (mg/dl; mean ± SEM) 
Day Treatment Group 
CC CF ECF 
0 31.90 ± 15.84* 18.68 ± 5.18 20.49 ± 6.78 
45 1301.43 ± 79.36 1339.18 ± 108.60 1308.80 ± 87.15 
90* 1018.40 ± 79.29^ 217.40 ± 24.05® 597.50 ± 115.36'^ 
:|e 
Treatment Groups: Cholesterol consuming (CC; n=6), Cholesterol-free (CF, n=6) and 
Ethanol-consuming and cholesterol-free (ECF, n=7). 
'For the CC group, n=5 at day 0. 
'Statistically significant (P < 0.05) differences between groups, means with same letter are not 
significantly different. 
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concentration (Table 8) were similar to that observed for the 
total cholesterol concentration at days 0, 45 and 90. 
The HDL-cholesterol concentration (Table 9) was increased 
in all groups after 45 days of cholesterol feeding. However, 
the high HDL values observed at day 45 may have reflected 
cholesterol contamination from the LDL fraction because the 
density contrast between lipoprotein fractions on day 45 were 
poorly delineated after ultracentrifugation, making 
separation difficult. This situation was not encountered 
when lipoproteins from the day 90 plasma samples were 
separated. On day 90, the HDL-cholesterol concentration of 
the CC and ECF animals was greater than that of the CF 
animals, but no significant differences (P < 0.05) were 
detected between the groups. 
Atherosclerotic lesion severity was evaluated on day 90 by 
the use of Sudan-IV staining and histological evaluation. 
Sudan-IV stain was used to delineate the percentage of 
surface area covered by atherosclerotic lesions on proximal 
segments, distal segments and the total area of the two 
segments. No significant differences (P < 0.05) were 
detected in the amount of Sudan-IV stained surface areas 
between the three groups (Table 10). When the aortic cross-
sections were evaluated, no significant differences (P < 
0.05) between the groups were detected in regards to the 
arterial outer perimeter, the area of intact smooth muscle 
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Table 8. Plasma LDL-cholesterol concentration on day 0, 45 
and 90. 
mg total /dl (mean ± SEM) 
Day Treatment Group 
CC CF ECF 
0 6.34 ± 21,80* 8.68 ± 1.50 30.17 ± 20.15 
45 754.02 ± 143.58 806.60 ± 143.58 647.39 ± 97.64 
90* 483.63 ± 79.29^ 205.18 ± 39.51® 312.77 ± 49.93® 
Treatment Groups: Cholesterol consuming (CC; n=6). Cholesterol-free (CF, n=6) and 
Ethanol-consuming and cholesterol-free (ECF, n=7). 
'For the CC group, n=5 at day 0. 
^Statistically significant (P < 0.05) differences between groups, means with same letter are not 
significanUy different. 
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Table 9. Plasma HDL-cholesterol concentration on day 0, 45 
and 90. 
Cholesterol (mg/dl; mean ± SEM) 
Day Treatment Group 
CC CF ECF 
0 29.90 ± 6.31" 15.65 ±1.13 21.11 ± 2.42 
45 252.43 ± 99.48 209.37 ± 40.22 253.92 ± 83.39 
90* 46.46 ± 5.16 17.92 ± 3.54 47.51 ± 15.95 
* 
Treatment Groups: Cholesterol consuming (CC; n=6). Cholesterol-free (CF, n=6) and 
Ethanol-consuming and cholesterol-free (ECF, n=7). 
'For the CC group, n=5 at day 0. 
^Statistically significant (P < 0.05) differences were not detected between groups at day 90. 
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Table 10. Atherosclerotic severity on day 90 expressed as 
the percentage of total aortic surface area 
staining positive with Sudan-IV stain. 
4: 
Aortic surface area stained m each treatment group 
(%; mean ± SEM) 
Segment Location CC CF ECF 
Proximal 63.03 ± 8.44 85.07 ± 7.19 64.10 ± 14.38 
Distal 63.72 ± 7.77 66.15 + 12.23 42.09 ± 11.71 
Total® 63.10 ± 8.26 81.84 ± 7.68 60.88 ± 13.57 
4: 
Treatment Groups: Cholesterol consuming (CC), Cholesterol-free (CF) and Ethanol-
consuming and cholesterol-free (ECF); no statistically significant (P < 0.05) differences 
between the groups were detected. 
®Total was derived from the sum of the proximal and distal areas staining positive divided by 
the sum of the two total areas. 
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and area of fatty streak involvement (Table 11). In 
addition, no significant differences (P < 0.05) between the 
groups were detected in regards to the cholesterol content of 
the aortic arch segments (Table 12). 
Data on hepatic cholesterol content (Table 12) expressed 
as mg cholesterol per gram of liver (wet weight), demonstrate 
that the CC group had significantly (P < 0.05) more 
cholesterol than did the ECF group. Furthermore, the total 
hepatic cholesterol content of the CC rabbits was also 
significantly (P < 0.05) greater than that of the CF and ECF 
groups. 
Discussion 
Continued cholesterol deposition and atherosclerotic 
development during administration of a cholesterol-lowering 
diet to rabbits has been observed by several investigators 
(Daugherty et al., 1986; Kappogoda et al., 1989; Jayakody et 
al., 1990; Albrecht and Schuler, 1965; Freidman and Byers, 
1963) . Due to the high CETP activity in rabbit plasma, 
cholesterol is also readily transferred from the HDL fraction 
to the VLDL and LDL fractions (Ha and Barter, 1982). In 
addition, cholesterol continues to be recycled back into VLDL 
and LDL particles as a result of continued hepatic 
95 
Table 11. Evaluation of aortic cross-sections collected on 
day 90 for total perimeter, vascular smooth muscle 
area and the area infiltrated by fatty streaks. 
Measurement' 
CC 
Treatment Grouo 
CF ECF 
Outer Per (mm) 14.46 ± 0.72 15.14 ± 0.71 15.17 ± 0.63 
SMCA (mm^ 4.42 ± 0.65 4.25 + 0.23 4.01 ± 0.23 
FSA (nun^ 3.35 ± 0.41 3.30 ± 0.97 2.93 ± 0.54 
Treatment Groups: Cholesterol consuming (CC), Cholesterol-free (CF) and Ethanol-
consuming and cholesterol-free (ECF); no statistically significant (P < 0.05) differences 
between the groups were detected. 
'Measurements expressed as mean ± SEM; Abbreviations: Outer Per, outer perimeter of the 
artery (mm); SMCA, area (mm^ of smooth muscle in the artery; FSA, area (nmi^) of artery 
containing lipid filled cells. 
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Table 12. Cholesterol content of the aortic arch and liver on 
day 90. 
Treatment 
Group 
Cholesterol Content (mean ± SEM) 
Segment from Aortic Arch Liver 
mg/g wet weight^ mg/segment* mg/g wet weight^ g/liver* 
CC 37.29 ± 2.00^ 14.81 ± 2.31^ 32,14 ± 2.40® 3.98 ± 0.33® 
CF 29.65 ± 1.00^ 10.70 ± Q.lT 17.41 ± 0.99^ 2.36 ± 0.30* 
ECF 36.90 ± 4.02^ 12.78 ± 2.10* 15.10 ± 2.65'^ 1.97 ± 0.31* 
4: 
Treatment groups: Cholesterol consuming (CC), Cholesterol-free (CF) and Ethanol-consuming 
and cholesterol-free (ECF). 
^Statistically significant differences (P < 0.05), means with the same letter are not significantly 
different. 
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lipoprotein synthesis (Daugherty et al., 1986). In this 
investigation, cholesterol apparently remained in the 
circulation after the cholesterol supplement was stopped and 
presumably continued to be deposited in the VLDL and LDL 
lipoprotein fractions as well as in atherosclerotic lesions. 
A similar theory to explain continued atherosclerotic 
development after cessation of cholesterol feeding has been 
suggested by Friedman and Byers (1963). 
Consumption of the CF diet between days 45 and 90 promoted 
a marked reduction of plasma triglyceride, VLDL-, LDL- and 
HDL- cholesterol concentrations from the day 45 values toward 
the day 0 values. However, the aortic arch cholesterol 
content, Sudan-IV stained area, and fatty streak cross-
sectional areas of the CC and CF groups were not different. 
Based on these observations, there is no evidence to suggest 
that the CF diet alone modified the development of 
atherosclerotic lesion development or promoted 
atherosclerotic regression. 
Comparison of the baseline plasma cholesterol 
concentration on day 0 (Table 6) reveals that a wide range of 
cholesterol concentrations were present in the total 
population. By comparison, base line total plasma 
cholesterol concentrations of between 84 ± 10 (mean ± SEM) 
and 43.6 ± 3.3 (mean ± SEM) were observed for two groups of 
similar sized male New Zealand White rabbits used in a study 
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by Jayakody et al. (1989). In contrast, the base line plasma 
cholesterol concentration of our CC group is clearly very 
high, and the values for the CF and ECF groups are similar to 
those obtained by Jayakody et al. (1989). 
It is possible that the high plasma cholesterol 
concentration in the CC group on day 0 could have predisposed 
this group to respond to their dietary cholesterol supplement 
in a manner different from that of the CF and ECF groups. 
However, because all three groups showed similar dramatic 
increases in total cholesterol to around 2300 mg/dl at day 
45, the initially high plasma cholesterol observed in the CC 
group was probably not an important factor during days 45 to 
90. Furthermore, baseline cholesterol concentrations have 
been suggested to be unimportant for determining whether New 
Zealand white rabbits will be resistant to 
hypercholesterolemia (Loose-Mitchell et al., 1991). In 
future experiments, this problem could be resolved by 
assigning the rabbits into the three groups with 
consideration of their baseline plasma cholesterol 
concentrations, such that rabbits with high, medium and low 
plasma cholesterol concentrations were equally distributed 
into the three groups. 
Atherosclerotic regression resulting from the removal of 
cholesterol from the diet of rabbits is correlated with the 
degree to which normal plasma cholesterol concentrations can 
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be re-achieved, the duration of cholesterol feeding and the 
severity of the atherosclerotic lesions established prior to 
administration of the regression diet (Adams, Morgan and 
Bayliss, 1973). In the present study, the diet-induced 
hypercholesterolemia was not entirely resolved in any group 
at the end of 90 days, and net cholesterol deposition and 
atherosclerotic development probably continued between day 45 
and 90 in all three groups. Continued deposition is probable 
because atherosclerosis in rabbits can be promoted by plasma 
cholesterol levels as low as 200 to 300 mg/dl (Adams et al., 
1982) . 
The CC group had a greater amount of hepatic cholesterol 
per gram of tissue than did either the CF and ECF groups. 
This observation suggests that rabbits in the CC group 
continued to absorb dietary cholesterol, but that the rate of 
cholesterol deposition into the arterial wall and the rate of 
atherosclerotic progression was similar for the three groups; 
an effect observed in previous investigations (Albrecht and 
Schuler, 1965; Bortz, 1968). 
Direct intravenous administration of HDL particles has 
been shown to induce atherosclerotic regression in spite of 
persistent hypercholesterolemia (Badimon et al., 1990). In 
their study, regression was presumably promoted by increased 
cholesterol efflux from atherosclerotic lesions into the 
added HDL particles, reducing the cholesterol content and the 
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severity of atherosclerotic lesions. Ethanol consumption by 
humans and rabbits is associated with increased HDL-
cholesterol concentrations and the inhibition of 
atherosclerotic development (Gaziano et al., 1993; Castelli 
et al., 1977; Klurfeld and Kritchevsky, 1981). The effect of 
ethanol-stimulated increases in HDL-cholesterol during 
administration of a cholesterol-free diet have not been 
evaluated. 
Administration of an ECF diet in this study was associated 
with a day 90 HDL-cholesterol concentration that was not 
significantly greater than that in rabbits receiving the CF 
and CC diets. In addition, atherosclerotic severity, defined 
in terms of aortic surface area, aortic fatty streak cross-
sectional area and aortic cholesterol content, was not 
significantly different among the CC, CF and ECF groups. 
Thus, the inclusion of dietary ethanol as supplement to a CF 
diet did not affect the atherosclerotic disease process. 
In future studies, it would be useful to evaluate the 
effects of ethanol on atherosclerotic regression when plasma 
cholesterol concentrations have been returned to normal 
levels for longer periods of time. It is under these 
conditions that one would expect dietary ethanol to have the 
greatest impact for stimulating net cholesterol efflux from 
atherosclerotic deposits as well as minimizing the amount of 
VLDL- and LDL-cholesterol available for deposition into 
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atherosclerotic lesions. However, it is also important to 
recognize that long treatment times may not be available to 
human patients suffering from coronary artery disease because 
of angina or disabilities related to their disease. 
This study used a rabbit model to evaluate the effects of 
dietary ethanol on human cholesterol-lowering diets. The 
data indicate that benefits are not associated with the 
inclusion of dietary ethanol in a cholesterol lowering diet. 
Previous studies had shown that dietary ethanol is associated 
with increased HDL-cholesterol and the suppression of 
atherosclerotic development in both humans and rabbits. In 
this study, dietary ethanol was associated with the 
maintenance of several risk factors for continued 
atherosclerotic development, including hypertriglyceridemia 
and impaired resolution of plasma hypercholesterolemia. The 
data suggest that consumption of dietary ethanol, during the 
administration of a cholesterol-free diet would not be of 
benefit to humans undergoing cholesterol-lowering dietary 
therapy. 
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CHAPTER 4. POTENTIATION OF VASOCONSTRICTIVE PROPERTIES IN 
AORTAS FROM ATHEROSCLEROTIC RABBITS FED A CHOLESTEROL-FREE 
DIET WITH AND WITHOUT DIETARY ETHANOL 
A paper to be submitted for publication in the 
Journal of Comparative Biochemistry and Physiology. 
Edward F. Wilson and Richard L. Engen 
Abstract 
The effect of dietary ethanol on atherosclerotic regression 
and vasoconstriction in atherosclerotic rabbits was addressed 
by feeding male New Zealand white rabbits (n=19) a diet 
enriched with 0.8% cholesterol for 45 days, followed by 
randomization to one of three diets for the next 45 days: l) 
Continued consumption of a cholesterol-rich diet (CC; n=6), 
2) Consumption of a cholesterol-free diet (CF; n=6), and 3) 
Consumption of a cholesterol-free diet supplemented with 
ethanol in the drinking water (10% v/v; ECF; n=7). On day 90 
the rabbits were killed and abdominal aortic rings (4 
rings/rabbit) were evaluated for constrictive force 
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generation. Data are expressed as mean ± SEM, means with the 
same letter are not significantly (P < 0.05) different. 
Atherosclerotic deposits were visually observed in 73 of the 
76 arterial rings evaluated. Norepinephrine (NE; lO'^M) 
promoted maximal contractile forces in the CC, CF and ECF 
groups of 3.69 ± 0.32^^, 5.09 ± 0.39*^ and 5.31 ± 0.30® grams, 
respectively. Potassium chloride (KCl; 80 mM) promoted 
maximal contractile forces in the CC, CF and ECF groups of 
4.01 ± 0.35'^, 5.04 ± 0.38-^® and 5.34 ± 0.47 grams®, 
respectively. The contractile forces developed in response 
to 200 mg/dl ethanol by the CC, CF and ECF groups were 51.4 ± 
7.5'^, 71.2 ± 12.6'^ and 104.9 ± 31.5'^, respectively. 
Contractions in the ECF group were more variable in terms of 
their response to ethanol and while statistical significance 
from the CC groups was not observed, the ECF diet does appear 
to promote increased contractile sensitivity in some arterial 
rings. Serotonin (10"'M) developed contractile forces in the 
CC, CF and ECF groups of 2.35 ± 0.24^^, 2.13 ± 0.21^ and 2.89 
± 0.59'^ grams, respectively. In conclusion: 1) Switching from 
a cholesterol-rich to an ECF diet promotes increased 
vasocontractile responses to NE, KCl and possible ethanol, 
and 2) Switching from a cholesterol-rich to a CF diet 
promotes increased vasoconstrictive responses to KCl. 
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Introduction 
Increased vascular sensitivity of human arteries to the 
vasoconstrictive properties of NE and 5-HT is a hallmark of 
atherosclerosis (Mudge et al., 1976; Golino et al., 1991). 
Sources of NE include release from nerve endings in the 
vessel or release directly into the blood from the adrenal 
glands. A primary source of 5-HT at atherosclerotic lesion 
sites includes platelet aggregation and degranulation (Golino 
et al., 1991). 
The cause of increased vascular sensitivity during 
atherosclerosis has not been conclusively determined, but a 
decrease in NE-mediated and 5-HT-mediated endothelium-
dependent relaxation has been implicated (Forstermann et al., 
1988; Minor et al., 1990). Increases in the number of 5-HT 
receptors and increases in the number of a,-adrenocetors have 
also been implicated (Nanda and Henry, 1980). Because the 
atherosclerotic process also involves changes in the 
morphology of vascular smooth muscle cells (Ross, 1993), 
receptor-independent changes in smooth muscle contractility 
may also be responsible. 
Ethanol promotes arterial vasoconstriction (Altura, Altura 
and Carella, 1983; Savoy-Moore et al., 1989), increased blood 
pressure (Maheswaran et al., 1991) and has been implicated 
with producing both vasospasm (Altura, Altura and Carella, 
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1983) and variant angina (Takizawa et al., 1984). In 
contrast to these health risks, moderate consumption of 
dietary ethanol by humans has been associated with a 
decreased incidence of coronary heart disease and overall 
mortality (Friedman and Kimball, 1986). Thus, dietary 
ethanol is associated with both health benefits and potential 
risks in regards to the coronary vasculature. 
Public interest in ethanol consumption has increased 
because of the association of ethanol consumption with 
improved vascular health by preventing atherosclerotic 
development (Klatsky and Armstrong, 1993). At the same time, 
public interest in lowering plasma-cholesterol concentrations 
by dietary modification has also increased (Patsch, Patsch 
and Gotto, 1989). The effect of dietary ethanol on vascular 
reactivity in atherosclerotic arteries during administration 
of a cholesterol-lowering diet has not been determined. This 
investigation protocol required the production of 
atherosclerosis in rabbits with a cholesterol-rich diet. 
Development of atherosclerosis was followed by the inclusion 
of dietary ethanol as part of a plasma-cholesterol lowering 
diet and the evaluation of differences in vascular reactivity 
to potassium chloride, ethanol, norepinephrine and serotonin 
resulting from the dietary change. 
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Materials and Methods 
Animal and Tissue Handling: Male New Zealand White rabbits 
weighing 1.9 to 3.0 kg were obtained from LSR Inc. Union 
Grove, Wisconsin. Rabbits were obtained as a set of 18, 
followed by an additional set of 5, staggered 45 days behind 
the set of 18. Rabbits were fed from a single manufactured 
lot of Teklad #0533 (Madison, Wisconsin) rabbit chow (140 
grams/day). The chow was made atherogenic by adding a 
cholesterol-supplement prepared by dissolving cholesterol in 
butylmethylphenol-free ethyl ether (1 gram/10 ml) and evenly 
dispersing the solution onto the rabbit chow. The ether was 
evaporated from the chow under a fume hood, leaving chow 
enriched with 0.8% cholesterol. 
Atherogenic chow was fed to all rabbits from days 0 to 45. 
On day 45, the rabbits were randomized to one of three 
treatments for the next 45 days: 1) Rabbits received the same 
atherogenic rabbit chow (Cholesterol-Consuming; CC; n=6), 2) 
Rabbits received chow with no cholesterol supplement 
(Cholesterol-free; CF; n=6), and 3) Rabbits received 10% 
dietary ethanol in their drinking fluid in addition to the 
cholesterol-free diet (ECF; n=7) . 
During the course of the experiment all rabbits had free 
access to the following drinking solutions. Water was 
administered between days 5 to 45 to all rabbits. Antibiotic 
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treatment of pneumonia was repeated for all rabbits at three 
different time (days 0 to 4, days 50 to 58 and days 71 to 80) 
and consisted of tetracycline (2 mg/ml) dissolved in Kool-
Aide (0.16% Kool-Aide; 5% sugar) for improved palatability. 
The Kool-Aide solution was also administered to all rabbits 
between days 45 and 90; this solution was supplemented with 
ethanol (10% v/v) for rabbits assigned to the ECF treatment 
group. Three rabbits died of pneumonia during the course of 
the experiment, and one rabbit was euthanized as a result of 
a handling injury; these rabbits were excluded from this 
experiment. 
For the determination of the in vitro vascular 
responsiveness on day 90, rabbits were anesthetized with 
sodium pentobarbital (40 mg/kg) administered into the ear 
vein prior to decapitation and removal of the aorta. 
Immediately upon removal of the aorta, a segment of abdominal 
aorta starting at the renal artery bifurcations and extending 
2.5 cm distally was cut free and placed in a modified-Krebs 
solution (115.21 mM NaCl, 4.70 mM KCl, 1.80 mM CaClz, 1.16 mM 
MgS04, 1.18 mM KH2PO4, 22.14 mM NaHCOa, 7.88 mM glucose and 
0.027 mM EDTA) and oxygenated with a gas mixture of 95% 
oxygen and 5% CO2 at 20°C. Adventitial tissues were then 
removed from the segment. Starting 2 mm distal to the renal 
arterial bifurcation and no more than 1 mm from any vertebral 
arterial bifurcation, four aortic cross-sectional rings (3 mm 
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long) were sequentially cut and numbered (#1 (most anterior), 
#2, #3 and #4 (most posterior)). At all times the tissues 
were handled with extreme care to ensure that the endothelial 
layer of these segments was not damaged. 
Evaluation of Aortic Rings: Evaluations of the four rings 
were made in vitro by using Grass FT03 force-displacement 
transducers (Grass Inc., Quincy, Massachusetts) and a Beckman 
R611 recorder (Beckman Instruments Inc., Schiller Park, 
Illinois) to monitor changes in the grams of tension 
maintained by the arterial rings. For the evaluation of 
vascular responses to KCl, NE and 5-HT the Beckman recorder 
was calibrated to measure tension in the range of 1-9 grams. 
For the evaluation of contractile responses to ethanol, the 
Beckman recorder was calibrated to measure tension in the 
range of 1 to 3 grams. 
Tissue baths were perfused with modified Krebs solution, 
oxygenated and maintained at 37°C. Baths were thoroughly 
flushed with modified Krebs solution at least every 30 
minutes. Arterial rings were mounted in triangular wire 
tissue holders, placed into the baths, attached to the force-
transducers and allowed to rest for 10 minutes. Then, 6 
grams of tension was gradually applied over a 20-second 
period. Ring tension was adjusted until a stable 2 gram 
resting tension could be achieved for 60 minutes or more. 
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Potassium chloride was then added at a final bath 
concentration of 80 mM and the gram scale set at 1-9 grams to 
develop a maximal tissue contractile force (Kishi and Numano, 
1984). The maximal contraction was defined by measuring the 
gram difference between the tension maintained just before 
KCl was applied and the peak developed tension. After the 
contractile maximum had been reached, the bath was flushed 
thoroughly at least three times. 
The dose of ethanol (200 mg/dl) was chosen to represent a 
level clinically observed in the human circulation and at a 
level that would generate contractile forces that were large 
enough to be confidently measured. By comparison in humans 
the lethal plasma concentration for ethanol is in the range 
of 350 to 900 mg/dl, with a plasma level of 200 mg/dl 
resulting in intoxication (Tierney, McPhee and Papadakis, 
1994). Preliminary trials with non-atherosclerotic rabbits 
showed that a dose of 200 mg/dl produced consistently 
observable contractile forces at a plasma ethanol level 
attainable by humans. As a result, the 2 00 mg/dl ethanol 
dose was chosen for evaluation of arterial contraction in 
this study. 
A period of at least 45 minutes was allowed to pass after 
KCl had been flushed. This period of time was found to be 
necessary for re-establishment of the 2 gram resting tension 
prior to administration of ethanol at a bath concentration of 
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200 mg/dl. Because contractile responses were occasionally 
absent and because the rate of contractile generation was 
occasionally slow, the bath was maintained with ethanol for a 
standard 20 minutes in all cases instead of flushing 
immediately after the contractile maximum had been reached. 
Tissue responses were measured on a 1 to 3 gram scale, and 
the contractile response was measured as before. 
For purposes of comparison with other studies, the effects 
of NE and 5-HT on arterial vasoconstriction were studied at a 
concentration near their ED^q values. In studies of 
atherosclerotic rabbit aortas (Henry and Yokoyama, 1980; 
Kishi and Numano, 1984; Kappagoda, Thomson and Senaratne, 
1990; Du and Woodman, 1992) , the ED50 of NE in rabbit aortas 
has been determined to be in the range of 10"' to 10"® M. The 
EDjo for 5-HT for rabbit aortas has also been suggested to lie 
in the range of 10"' to 10"^ M (Henry and Yokoyama, 1980; Kishi 
and Numano, 1984). In this study, an agonist concentration 
of 10'' M was chosen to represent the ED50 for NE and 5-HT. 
A final 45-minute period followed after the ethanol was 
flushed, during which a 2 gram tension was re-established for 
the rings. An ED^q dose of NE was administered to the baths 
containing segments #l and #3, and an EDjq dose of 5-HT was 
administered to the baths containing segments #2 and #4. 
After the maximal response was reached, the tissues were 
removed and stored at 4°C in a separate container of Krebs 
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solution with 95% 02-5%C02 aeration. Within 12 hours of 
removal from the bath, the weight of each ring was determined 
and the inner arterial lumen was examined for the presence of 
raised white atherosclerotic lesions. 
Chemical Preparation: Potassium chloride at a concentration 
of 4.00 M was used for dilution throughout the study. 
Ethanol at a concentration of 20% (v/v) was used for dilution 
throughout the study. Norepinephrine in the bitartrate salt 
was prepared in deionized water containing 0.1% ascorbate as 
a preservative and frozen at -20°C, then thawed and diluted 
to 10'® M in deionized water and stored for 1-4 hours at 4®C 
until final dilution in the bath at 10"' M. Serotonin (10"^ M) 
was prepared daily by dissolving the 5-HT in deionized water 
and stored at 4°C prior to final dilution in the bath at 1 X 
10-' M. 
Statistical Analysis: Data are presented as the mean ± the 
standard error of the mean (SEM). Analysis of variance was 
performed by using SAS to detect the presence of group 
differences (P < F 0.05). When group differences were 
detected by the analysis of variance, Duncan's Multiple 
Comparison test was used to test for significant differences 
(P<0.05) between individual group means. 
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Results 
On day 90, the rabbits in the CF, ECF and CC groups 
weighed 3.74 ± 0.14, 3.82 ± 0.11 and 3.52 ± 0.14 kg, 
respectively, with no statistically significant differences 
observed. Arterial rings of the CF, ECF and CC groups 
weighed 9.83 ± 0.42, 10.21 ± 0.44 and 9.78 ± 0.28 milligrams, 
respectively, with no significant differences observed. 
After being weighed, the inner lumen of the arterial rings 
were examined and raised white atherosclerotic lesions were 
observed in 73 of the 76 total arterial rings. 
The contractile responses to 80 mM KCl (Figure 1) revealed 
that rings from rabbits in the ECF group generated the 
greatest contractile force (5.34 ± 0.47 g). This force was 
greater than that developed by the CF group (5.04 ± 0.38 g) 
and significantly (P < 0.05) greater than the force (4.01 ± 
0.35 g) developed by the CC group. 
Arterial rings were then treated with ethanol (200 mg/dl) 
and the contractile responses evaluated. The sample 
recording from an ECF rabbit is presented in Figure 2a shows 
a slowly developed and maintained contractile curve. The CC, 
CF and ECF groups generated maximal contractions of 51.6 ± 
7.5, 71.2 ± 12.6 and 104.9 ± 31.5 milligrams, respectively 
(Figure 2b). The F value for intergroup differences 
resulting from administration of 200 mg/dl ethanol was 2.12 
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Figure 1. Maximal contractile force generated by arterial 
rings in response to 80 mM potassium chloride. Abbreviations: 
CC, cholesterol consuming; CF, cholesterol-free, and ECF, 
Ethanol-consuming and cholesterol-free. Data are represented 
as mean ± SEM. 'Significantly different from CC group (P < 
0.05). 
Grams Tension Developed 
Figure 2. Maximal contractile force generation by arterial 
rings in response to 200 mg/dl ethanol. a) Sample recording of 
the contractile response by a ring from an ECF rabbit. b) 
Comparison of the maximal contractile force generated by all 
groups. Abbreviations; CC, Cholesterol consuming; CF, 
Cholesterol-free, and ECF, Ethanol-consuming and cholesterol-
free. Data represented as mean ± SEM; 'Significantly different 
from CC group (P < 0.05). Data are represented as mean ± SEM; 
no statistically significant (P < 0.05) differences were 
detected between groups. 
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(Pr>F= 0.15), indicating only a trend toward significant 
differences between the groups. 
Although statistically significant intergroup differences 
were not detected, arteries from the ECF rabbits had the 
greatest mean contraction in response to 200 mg/dl ethanol 
and the largest SEM. In contrast, the arterial rings from 
the CC rabbits had the smallest mean and a relatively narrow 
SEM. The range of the maximal contractile force generated by 
the individual rings within the CC group were 0 to 110 
milligrams, within the CF group the range was 0 to 180 
milligrams and within the ECF group the range was 0 to 310 
milligrams. The range of the mean contractile force 
generated by the four rings from each rabbit in the three 
groups were 35 to 86, 25 to 116 and 11 to 205 milligrams for 
the CC, CF and ECF groups, respectively. 
Norepinephrine (10"' M) applied to ring segments #1 and #3, 
generated maximal contractile forces of 3.69 ± 0.32, 5.09 ± 
0.39 and 5.31 ± 0.30 grams for the CC, CF and ECF groups, 
respectively (Figure 3). The responses of the CF and ECF 
groups were both significantly greater (P < 0.05) than that 
of the CC group. 
When 5-HT (10"' M) was applied to arterial ring segment #2 
and #4 (Figure 4), maximal contractile forces of 2.35 ± 0.24, 
2.13 ± 0.21 and 2.89 ± 0.59 grams were generated by the CC, 
CF and ECF groups, respectively. No statistically 
Figure 3. Maximal contractile force generated by arterial 
rings in response to 10"' M norepinephrine. Abbreviations; CC, 
cholesterol consuming; CF, cholesterol-free, and ECF, Ethanol-
consuming and cholesterol-free. Data are represented as mean 
± SEM; 'significantly different from CC group (P < 0.05). 
Grams Tension Developed 
Figure 4. Maximum contractile force generated by arterial 
rings in response to 10"' M serotonin. Abbreviations; CC, 
cholesterol consuming; CF, cholesterol-free, and ECF, Ethanol-
consuming and cholesterol-free. Data are represented as mean 
± SEM; no statistically significant (P < 0.05) differences were 
detected between groups. 
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significant differences in the forces generated by the groups 
were observed. 
Discussion 
This investigation of atherosclerotic rabbits demonstrates 
that an ECF diet promotes a significant increase in 
vasoconstrictive force generation in response to KCl and NE 
when compared to rabbits consuming a CC diet. Furthermore, a 
trend toward ethanol-induced contractile potentiation was 
also observed in regards to the ECF diet. However, dietary 
ethanol did not potentiate increases in the contractile force 
generated in response to 5-HT. When the CF group was 
compared to the CC group, only the NE response was 
significantly different. Because no differences between the 
CC, CF and ECF groups were noted in regards to rabbit body 
weight or arterial ring weight, the increased contractile 
forces associated with ethanol consumption were apparently 
not associated with differences in either the weight of the 
rabbits or the weight of the arterial rings. 
Aortic strips from atherosclerotic rabbits treated with 
KCl have been observed to have a greater maximal contractile 
force when compared to non-cholesterol-fed controls (Merkel 
et al., 1990; Kishi and Numano, 1984). In addition, a 
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reduction in the ED50 of KCl for atherosclerotic rabbit aortas 
has also been demonstrated (Ibengwa and Suzuki, 1986). These 
studies of KCl-mediated vasoconstriction suggest that 
receptor-independent changes which modify the 
vasoconstrictive properties of arteries are associated with 
atherosclerotic development. 
The present investigation carries the trend a step further 
by suggesting that switching atherosclerotic rabbits from a 
cholesterol-rich to a cholesterol-free diet promotes 
increased contractile force generation, when compared to 
rabbits maintained on a cholesterol-supplemented diet. The 
fact that KCl induced contractions in the ECF group were 
significantly greater indicates that at least part of the 
increased contractile ability is due to non-receptor mediated 
contractile effects. This surprising result suggests that, 
in terms of sensitivity to vasospasm, animal health might be 
deleteriously effects by the switch to a cholesterol-free 
diet, as occurs when humans consume a lipid lowering diet to 
treat hypercholesterolemia. 
Ethanol-induced contractions have been observed in 
arterial strip preparations from the canine coronary artery 
and arterial rings from the human umbilical artery (Altura, 
Altura and Carella, 1983; Savoy-Moore et al., 1989). It has 
been demonstrated that clinical levels of circulating ethanol 
inhibit acetylcholine stimulated release of endothelium-
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derived relaxing factor (Hatake, Wakabayashi and Hishida, 
1993) . Acute ethanol administration has also been shown to 
inhibit the basal production of endothelium-derived relaxing 
factor (Persson and Gustafsson, 1992). The administration of 
an endothelium-dependent relaxation inhibitor (nitro-L-
arginine) has been shown to promote small contractile 
responses that are similar to those generated by ethanol in 
this investigation (Minor et al., 1990). 
Based on the similarity of the contractile effects 
produced by inhibition of EDRF and the contractile effects 
created by ethanol administration in this investigation, one 
could speculate that the contractions observed in this 
investigation might be caused by ethanol-dependent inhibition 
of basal endothelium-dependent relaxation, thereby 
sensitizing the artery to underlying constrictive tendencies. 
Even though the ethanol-induced contractions observed in 
this investigation were small relative to those generated by 
KCl, NE or 5-HT, it must be remembered that blood flow 
through a vessel is proportional to the fourth power of the 
radius. As a result, very small changes in the radius of a 
vessel can have very large effects on blood flow. In 
addition, because the lumen of an atherosclerotic vessel may 
already be considerably filled in by the atherosclerotic 
lesion mass, a relatively tiny additional decrease in lumen 
diameter could promote a deficiency in oxygen supply. 
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resulting in angina or heart attack. The potential of small 
changes in diameter to affect blood flow is probably 
important in understanding why ethanol consumption by some 
human patients is a stimulant for variant angina (Takizawa et 
al., 1984). 
For the ethanol-mediated contractions observed in this 
investigation, only a trend toward differences between groups 
could be demonstrated. The arteries of the CC groups showed 
a tight cluster of relatively lower contractile responses 
(51.6 ± 7.5). In contrast, ECF treated rabbits had a mean 
and SEM (104.9 ± 31.5) approximately twice that observed for 
the CC group. These observations support a trend toward 
differences between the CC and EFC groups and suggest that 
ethanol consumption may potentiate sensitivity to ethanol-
induced contraction. 
Previous studies have demonstrated that contractile 
properties mediated by 5-HT are potentiated by 
atherosclerosis (Kishi and Numano, 1984; Henry and Yokoyama, 
1980; Kalkman, Neumann and Branner, 1989) and an increase in 
the number of 5-HT receptors has also been observed in 
atherosclerotic rabbits (Nanda and Henry, 1980). 
Constrictive hyper-reactivity in atherosclerotic rabbits has 
been associated with the 5-HT2 receptor (Kalkman, Neuman and 
Braunel, 1989). Because atherosclerotic lesions were 
observed in the arterial lumens of 73 or the 76 arterial 
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segments used in this investigation, the arteries of the CC, 
CF and ECF groups were presumed to be 5-HT hyper-reactive at 
the beginning of the second 45 day period. The present 
investigation suggests that neither the CF nor the ECF diet 
have an effect on 5-HT mediated contraction. 
In humans, hyper-reactivity to adrenergic stimulation has 
been clearly linked with atherosclerotic development (Chester 
et al., 1980; Mudge et al., 1976). It has been demonstrated 
by in vivo experiments with rabbits and dogs, that high 
levels of plasma low-density lipoprotein cholesterol 
potentiate aj-adrenergic vasoconstriction (Bloom et al., 
1975; Hof and Hof, 1988). An increase in the number of a,-
adrenergic receptors has also been observed in 
atherosclerotic rabbit aortas (Nanda and Henry, 1980). 
Furthermore, Du and Woodman (1992) observed a transient 
increase in pressor responses to NE and phenylephrine after a 
high cholesterol diet had been administered for 4 weeks. In 
contrast to the observations of Du and Woodman (1992), 
several studies of rabbits fed atherosclerotic diets have 
determined that, when aortic sensitivity is evaluated in 
vitro, vascular sensitivity to NE and phenylephrine can 
remain unchanged or become slightly depressed (Ibengwa and 
Suzuki, 1986; Kishi and Numano, 1980; Verbeuren et al., 1983; 
Verbeuren et al., 1986). 
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The contractile properties of the thoracic aorta and the 
effects of administration of a cholesterol-free diet to 
atherosclerotic rabbits was evaluated by Kappagoda et al. 
(1990). They did not observe significant changes in NE 
induced contractile forces after feeding a 2.5% cholesterol 
diet to rabbits for 3 weeks followed by administration of a 
cholesterol-free diet for the next 12 weeks. In a similar 
study (Kappogoda et al., 1989) fed 2.0% cholesterol diet for 
6 weeks, followed by a CF diet for an additional 36 weeks, 
after which again differences in NE sensitivity did not 
develop. 
The results observed by Kappogoda et al. (1989) and 
Kappagoda, Thomson and Senaratne (1990) are in contrast to 
the results observed in our investigation, where significant 
changes in the vascular responsiveness to NE were linked to 
consumption of a CF diet. The lower amount of cholesterol 
administered to the rabbits in our study, 0.8% (w/w) and the 
relatively short period of administration of a cholesterol-
free diet may have been a cause for these differences. 
The present investigation suggests that changes in diet, 
from a cholesterol-rich to a CF status, promote potentiation 
of NE-induced contractions. Because excessive a,-adrenergic 
stimulation in humans has been implicated in causing 
essential hypertension and angina pectoris, our results 
suggest that if a human is switched from a high cholesterol 
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diet to a low cholesterol-diet, especially one including 
ethanol, their vasculature would become more sensitive to NE 
mediated vasoconstriction, but not to 5-HT mediated 
vasoconstriction. 
While several studies have suggested that consumption of 
dietary ethanol inhibits the development of atherosclerosis, 
the effect of ethanol on the development or regression of 
previously existing atherosclerosis has remained 
undetermined. This investigation evaluated the effect of a 
CF diet on aortic contractile properties and indicates that 
when ethanol is administered as part of a CF diet to 
atherosclerotic rabbits, ethanol induces changes in the 
artery that potentiate constriction. Clinically, it is an 
assumption that a CF diet by atherosclerotic patients will 
promote an improvement of vascular health (Patsch, Patsch and 
Gotto, 1989). However, based on the increased tendency 
toward vasospasm, this investigation suggests that 
circulatory health of humans might be deleteriously affected 
by changing from a CC diet to a cholesterol-free diet and 
especially by including dietary ethanol in a CF diet 
administered for the treatment of atherosclerosis. 
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CHAPTER 6. GENERMi CONCLUSIONS 
The data in this dissertation suggest that dietary ethanol 
is not beneficial to human health. It demonstrates how 
ethanol causes constriction of umbilical arteries and the 
constriction of ovine umbilical arteries could be important 
for modeling how dietary ethanol causes fetal alcohol 
syndrome in human infants. This dissertation demonstrates 
that constriction of arteries in atherosclerotic rabbits fed 
a cholesterol-free diet actually increases constrictive force 
generation in response to norepinephrine. In terms of 
vasoconstriction, the data suggest that ethanol consumption 
as part of a cholesterol-free diet is associated with 
increased contractile force generation in response to 
potassium chloride and ethanol, as well as norepinephrine. 
Finally, the research demonstrates that in rabbits 
atherosclerotic regression is not promoted by the short-terra 
removal of cholesterol from the diet and that inclusion of 
ethanol in the diet does not induce atherosclerotic 
regression. Furthermore, because the ethanol diet was also 
associated with the maintenance of high plasma triglyceride 
and cholesterol concentrations, both of which are known risk 
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factors for atherosclerotic development, ethanol should be 
contraindicated during administration of cholesterol-free 
diets. 
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APPENDIX 1. STATISTICAL ANALYSIS OF TIME-DEPENDENT 
CHANGES IN PLASMA LIPID CONCENTRATIONS. 
Introduction 
The investigation of the effects of a cholesterol-lowering 
diet administered with or without dietary ethanol, described 
in Chapter 3, included both time and treatment dependent 
changes in the plasma lipid profile. Treatment-dependent 
changes and the their statistical significance have been 
addressed previously in Chapter 3. However, the complicated 
nature of the experimental subjects made statistical 
evaluation of time-dependent changes rather complicated and 
difficult to interpret. The experiment is complicated by the 
fact that all animals were part of a single population of 
rabbits between days 0 and 45, and that only after blood 
sampling on day 45 were these animals randomized to three 
different treatment groups. 
Personal communications with Dr. D.F. Cox in the 
(Department of Statistics, Iowa State University) revealed 
that a perfect statistical test to evaluate the statistical 
significance of these time-dependent changes is not 
available. Because of this fact, time-dependent changes in 
Chapter 3 were described in qualitative terms. Dr. Cox 
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suggested that one of the most easily interpretable 
statistical tests for time-dependent changes would be 
Student's t-test. However, there are some problems 
associated with using a Student's t-test for this purpose 
which need to be addressed. 
One of the requirements for the proper use of a Student's 
t-test is that there be two different populations. While 
different populations were available at day 90, data from day 
0 and 45 were collected from a single population. As a 
result, one of the primary requirements for the proper use of 
a Student's t-test was broken. In regards to publication and 
potential confusion associated with the misuse of Student's 
t-test, the statistical analysis of time-dependent changes in 
the lipid profile is addressed in this appendix and not in 
Chapter 3. 
Statistical Methods 
A Student's t-test was used to evaluate the statistical 
significance of the time-dependent changes in plasma lipid 
concentrations. To use the Student's t-test for this 
purpose, the populations at days 0 and 45 were, from the 
standpoint of statistics, considered as populations that were 
separate from the populations receiving the cholesterol 
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consuming (CC), cholesterol-free chow (CF) and cholesterol-
free chow with ethanol supplement (ECF) diets at day 90, when 
in fact they were not separate. The software used for this 
test was provided on the B-stat statistical program (Mc Graw 
Hill Inc., New York). This program utilized the means and 
standard errors of the mean to determine a T-value and 
probability of significance. 
A detailed example of how the evaluations were carried out 
is as follows for the plasma triglycerides of the CF group at 
the end of the experiment (day 90, 80.0 ± 11.8 mg/dl) verses 
the plasma triglycerides of the entire population of rabbits 
treated alike at day 0 (54.9 ± 7.7 mg/dl). The t-value was 
calculated to be -1.661 and the P < 0.111. 
Results and Discussion 
The mean and standard error of the mean for plasma 
triglycerides, total cholesterol, VLDL-cholesterol, LDL-
cholesterol and HDL-cholesterol of the entire population is 
presented in Table 1, the day 90 values were described in 
Chapter 4. Statistical analysis of the differences between 
the day 45 and day 90 values, and between the day 0 and day 
90 values are summarized in Table 2. 
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Table 1. Plasma lipid data for the entire population of 
animals treated alike on days 0 and 45, expressed 
as the representative mean ± SEM.* 
mg/dl Day 0 Day 45 
Triglycerides 54.9 ± 7.75 437.9 ± 49.17 
Total Cholesterol 77.0 ± 15.51 2281.7 ± 133.96 
VLDL-Cholesterol 23.0 + 5.21 1316.4 ± 56.1 
LDL-Cholesterol 32.2 ± 10.67 731.3 ± 63.4 
HDL-Cholesterol 21.7 ± 2.31 238.6 ± 42.8 
4: 
Abbreviations: SEM, Standard error of the mean, VLDL, Very low-density lipoprotein; LDL, 
Low-density lipoprotein; HDL, high density lipoprotein. 
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Table 2. Results of Student T-tests comparing day 45 
population means obtained on day 90 for the CC, 
CF and ECF groups. 
Day 90 Group* Dav 45 vs Dav 90 
P-value 
Dav 0 vs Dav 90 
P-value 
Plasma Trielvcerides 
CC < 0.048 < 0.000 
CF < 0.000 < 0.111 
ECF < 0.967 < 0.000 
Total Cholesterol 
CC < 0.010 < 0.000 
CF < 0.000 < 0.000 
ECF < 0.000 < 0.000 
VLDL-Cholesterol 
CC < 0.009 < 0.000 
CF < 0.000 < 0.000 
ECF < 0.000 < 0.000 
LDL-Cholesterol 
CC < 0.000 < 0.000 
CF < 0.000 < 0.000 
ECF < 0.044 < 0.000 
HDL-Cholesterol 
CC < 0.030 < 0.407 
CF < 0.008 < 0.020 
ECF < 0.012 < 0.000 
Abbreviations: CC, Cholesterol consuming; CF, Cholesterol-free; ECF, Ethanol-
consuming and cholesterol-free. 
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The data shown in Table 2 support the idea that inclusion 
of ethanol in the lipid lowering diet of hypercholesterolemic 
rabbits inhibits the resolution of the developed 
hypercholesterolemia in association with a cholesterol-
supplemented diet and that consumption of a cholesterol-free 
diet without ethanol will be the best for promoting a return 
of high plasma triglyceride and cholesterol concentrations to 
normal values. However, when considering these conclusions 
it is again important to remember that the use of a Student's 
t-test to make these comparisons requires that one neglect 
one of the primary rules for the use of a Student's t-test, 
that of separate populations. 
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APPENDIX 2. SHEEP UMBILICAL ARTERIES AND THE VASOCONSTRICTOR 
DOSE-RESPONSE RELATIONSHIP FOR ETHANOL: PRELIMINARY DATA. 
Introduction 
Dietary ethanol is the cause of fetal alcohol syndrome in 
human infants; therefore, ethanol consumption can have a 
profound and permanent effect on the health of the unborn 
fetus (Clarren and Smith 1978). The pathological mechanism 
of fetal alcohol syndrome has not been determined, but a 
reduction in fetal oxygen supply has been implicated. 
Because ethanol is known to have a vasoconstrictive effect on 
arterial smooth muscle, ethanol could promote a reduction in 
fetal blood flow by reducing arterial diameter and increasing 
blood flow resistance (Mukherjee and Hodgen 1982; Altura et 
al. 1983; Savoy-Moore et al. 1989). Changes in prostaglandin 
E have also been associated with the promotion of teratogenic 
changes associated with FAS (Randall et al. 1991). 
Sheep umbilical arteries can be used as a human model 
(Fiscus and Dyer 1981) because the ovine fetus is similar to 
the human fetus in respect to its weight, blood flow 
requirements and umbilical artery dimensions. The effect of 
ethanol has been previously characterized for constriction of 
human umbilical arteries (Altura et al. 1983; Mukherjee and 
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Hodgen 1982; Savoy-Moore et al. 1989; Fiscus and Dyer 1981), 
but the effects of ethanol in the ovine model have not been 
determined. 
This preliminary investigation sought to generate a dose-
response relationship for ethanol promoted ovine umbilical 
artery vasoconstriction. However, more importantly this 
short investigation served to familiarize the investigator 
with the techniques used in handling isolated tissues and 
administration of drugs to isolated tissues. The data 
presented in this study represents a very small number of 
experiments because the supply of animals was terminated 
prematurely due to a shortage of animals from the Principal 
Investigator Dr. D. C. Dyer (Department of Veterinary 
Physiology and Pharmacology, Iowa State University). 
Materials and Methods 
At 10 to 20 days pre-term, three ewes were euthanized with 
a overdose of sodium pentobarbital/magnesium chloride 
solution (Sleep-Away, Fort Dodge Laboratories, Fort Dodge, 
Iowa). Fetuses were removed after abdominal laparotomy, and 
the umbilical cord was cut 1.5 to 2.0 cm from its origin at 
the fetal abdomen. The distal end of the umbilical cord was 
cut at the first cotyledonous branch point. Umbilical cord 
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removal was completed within 10 minutes of anaesthetic 
induction, and the cord was immediately placed in a modified 
Krebs solution (115.21 mM NaCl, 4.70 mM KCl, 1.80 mM CaClj, 
1.16 mM MgS04, 1.18 mM KH2PO4, 22.14 mM NaHCOj, 7.88 mM glucose 
and 0.0267 mM EDTA) and oxygenated with a gas mixture 
consisting of 95% Oj and 5% COj. The umbilical arteries were 
removed from the umbilical cord within 60 minutes of removal 
from the fetus. The adventitial tissue of the arteries was 
removed, and the arteries were stored at 4°C and oxygenated 
with the 95% Oj and 5% COj gas mixture for 1 to 24 hours 
before final sectioning and physiological evaluation. 
Just prior to constrictor evaluation, the umbilical 
arteries were returned to room temperature and cut into 4 mm 
long cross-sectional rings. Care was taken to avoid 
disruption of the endothelium at all times. After 8 rings 
had been cut from each umbilical artery, the rings were 
attached to fine wire triangles and mounted in 10 ml tissue 
baths. The tissue baths were maintained at 37°C, oxygenated 
with the 95% Oj and 5% Oj gas mixture and perfused with 
modified Krebs. 
The arterial ring triangles were attached to Grass FT03 
force-displacement transducers (Grass Instruments, Quincy, 
Illinois) linked to a Beckman R611 recorder (Beckman 
Instruments, Schiller Park, Illinois) or monitoring and 
recording changes in the tension maintained by the arterial 
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rings. After being placed in the tissue baths, 12 grains of 
tension was applied over a 20 second period. The rings were 
then allowed to relax over the next 40 minutes, after which 
the tension was gradually adjusted until a 2.0 gram resting 
tension could be maintained. 
Two slightly different protocols were used to evaluate the 
vasoconstrictive effects of ethanol, and, for this 
experiment, their results were considered equivalent. In one 
protocol, KCl at a bath concentration of 140 mM was used to 
develop a maximal contraction in all arterial rings. The KCl 
was then flushed, the 2 gram resting tension re-established 
and ethanol (95% ethanol. Chemistry Stores, Iowa State 
University, Ames, Iowa) administered at 0, 50, 100 and 200 
mg/dl bath concentrations, with two rings of the eight 
receiving each dose. The second protocol applied an ethanol 
dose of 150 mg/dl to three rings, an ethanol dose of 300 
mg/dl to three rings and a 140 mM dose of KCl was applied to 
the remaining two rings. The magnitude of the ethanol 
induced contractions were expressed as a percentage of the 
respective KCl-induced contractile maximum. 
In one animal, the endothelium was destroyed in three 
rings by gently turning a metal bar around inside the 
arterial lumen three times prior to administration of KCl and 
ethanol; the endothelium was left intact in the remaining 
four rings (the eighth ring was removed from the study due to 
149 
accidental damage during handling). Potassium chloride (140 
mM) was then administered followed by ethanol (200 mg/dl) and 
the effects of endothelial cell removal were evaluated by a 
paired t-test. All data presented in this experiment were 
expressed as the mean ± standard deviation. 
Results 
The preliminary observations from the three separate 
trials are reviewed in Figure 1. Isolated tissue bath 
ethanol concentrations of 50 to 3 00 mg/dl produced responses 
ranging from no observed contraction to a contractile force 
that was 3.81% of the KCl response generated by the artery, 
respectively. A sham administration of deionized water 
resulted in no contraction. A regression line described by 
the equation y= (0.0113)(x)+(-0.216) was obtained from the 
data points collected in the three trials (correlation 
coefficient= 0.929). The average KCl response for the 
arterial rings used to generate the data in Figure 1 was 7.07 
± 0.46 grams. 
Finally, the umbilical artery from a single lamb was 
removed and the endothelial rings with (4 rings) and without 
an intact endothelium (3 rings) were compared (Figure 2). In 
rings with an intact endothelium, ethanol (200 mg/dl) 
Figure 1. Contractile force generation of sheep umbilical 
arteries induced by ethanol. Data were collected from three 
different animals denoted by closed circles, open circles and 
open triangles; the heavy line indicates the regression line 
for all data points. 
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Figure 2. Comparison of contractile force generation by sheep 
umbilical arteries with or without an intact endothelium (mean 
± SEM). 
Percent of KCl Derived Force 
O O - ' - ' M M O J O J - l ^ - f ^ - C n c n C T )  
o c n o c n i o c n i D U i b L n b u i b  
With Endothelium 
With Endothelium Destroyed 
154 
promoted a contraction that was 1.86 ± 0.71% of the KCl 
response. When the endothelium was destroyed the response 
was 3.73 ± 2.04%. The significance for this difference was 
P < 0.14. The average KCl response of the rings with intact 
endothelium was 11.56 ± 1.56 grams, and the average KCl 
response for rings with a destroyed endothelium was 10.10 ± 
1.50 grams. 
Discussion 
Ovine umbilical arteries, like their human counterparts, 
are sensitive to the constrictive effects of ethanol. 
Comparisons between the constrictor forces generated in this 
and previous investigations are difficult because previous 
studies have used arterial strip preparations (Savoy-Moore et 
al. 1989; Altura et al. 1983; Fiscus and Dyer 1981) or 
morphological changes in artery appearance (Mukherjee and 
Hodgen 1982). In contrast, this investigation is the first 
to examine ethanol-induced contractions in a ring 
preparation. 
In our investigation a 50 mg/dl dose of ethanol was found 
to represent the approximate threshold for detection of 
ethanol induced constriction in ovine umbilical arteries. 
The threshold suggested by our study is supported by Altura 
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et al. (1983) who determined that 52 ± 5.8 mg/dl was the 
threshold for a human strip preparation. However, a lower 
human strip-threshold has been observed by Savoy-Moore et al. 
(1989) who detected contractions at an ethanol dose of 
I mg /dl. 
The difficulty with measuring ethanol-induced contractile 
effects at lower concentrations stems from a loss in the 
ability to maintain a stable baseline tissue tension needed 
to observe such small vasoconstrictive forces. When 
transducers are set to detect changes of as little as 10 to 
30 mg of tension, they also tend to record changes in tension 
produced by aeration bubbles bouncing off of the strings 
attaching the rings to their force transducers, as well as 
electrical static in the Beckman recorder itself. As a 
result, it is very difficult to record changes of tension 
that are much smaller than about 3 0 mg. 
The physiological mechanisms responsible for ethanol-
induced vasoconstriction have not been determined, but have 
been suggested to include inhibition of endothelium-dependent 
relaxation (Hatake et al. 1993; Persson and Gustafsson 1992) 
or potentiation of the constrictor properties of angiotensin 
II (Savoy-Moore et al. 1989). Altura et al. (1983) observed 
that the maximal ethanol induced contractions of human 
umbilical artery were observed to be 68.8% of the maximal 
serotonin derived contraction. L-N°-monomethyl-arginine is a 
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compound that completely abolishes the effects of 
endothelium-dependent relaxation in rabbit aortas and 
promotes a 20% increase in tension (Minor et al. 1990). 
Because the maximal ethanol-derived effects are much greater 
than that observed when EDRF is pharmacologically abolished, 
is must be assumed that ethanol derives its constrictor 
effects by acting on several mechanisms. This assumption is 
supported by the observations made in this investigation, 
where a trend suggestive of potentiated ethanol-induced 
constriction was observed when the endothelium, and 
endothelium-dependent relaxant effects were mechanically 
destroyed. 
Ethanol may also influence FAS by mediating changes in PGE 
metabolism. Prostaglandin E is known to induce contractions 
of the myometrium (Gordeau et al., 1992); but whether 
ethanol-induced changes in PGE are linked to changes in 
arterial contractile force during pregnancy is unknown. 
Hocking et al. (1993) determined that in sheep, establishment 
of a 148 to 164 mg/dl plasma ethanol concentration is 
associated with a significant (P < 0.05) increase of 44% in 
placental secretion of PGEj when compared to pre-ethanol 
levels. Furthermore, Randall et al. (1991) administered 
aspirin (3 00 mg/kg), to block PGE synthesis, one hour prior 
to the administration of a 5.8 g/kg intragastric dose of 
ethanol. Pre-administration of aspirin prior to ethanol was 
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associated with an 80% reduction in the plasma PGE 
concentration, significant at P< 0.05, and a 50% reduction in 
the frequency of malformations observed per litter. 
In conclusion, this preliminary investigation suggests 
that ovine umbilical arterial rings respond to ethanol in a 
manner similar to that observed in human arterial strips. 
Furthermore, this investigation suggests that the ovine 
umbilical artery ring-preparation could be useful for the 
evaluation of the effects of ethanol on the human umbilical 
vasculature. 
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